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Biomolecules have evolved in nature with the ability to synthesize materials with 
uniquely interesting properties in response to environmental stress. Bio-mediated 
materials are often synthesized under conditions of neutral pH and ambient temperature 
and pressure from a limited set of biologically available metals. This thesis presents 
work done in an effort to 1) identify biomolecules capable of mediating the synthesis of 
nanomaterials in vitro, 2) further understand the circumstances that promote bio-
mediated materials synthesis and 3) apply the knowledge gained to a novel intracellular 
protein labeling scheme. 
In vitro selection experiments involving RNA, phagemids, or whole cells can 
identify biomolecules that bind tightly to or mediate the formation of inorganic materials. 
Through this work, iterative cycles of RNA selections have identified RNAs that mediate 
the formation of metal oxide nanoparticles. The selection pressure required RNA-
mediated assembly of Co and/or Fe into a solid that responded to a magnetic field 
under ambient conditions.  
The ability of peptides selected via phage display to mediate the formation of 
inorganic nanoparticles is now well established. However, the atomic-level interactions 
between the selected peptides and the metal ion precursors remain largely obscure.  
We identified a new peptide that is capable of mediating the formation of Ag 
nanoparticles. Surprisingly, nanoparticle formation required the presence of peptide, 
HEPES buffer, and light. Peptide epitope mapping indicated crucial residues for particle 
formation. Additionally, once immobilized onto a surface, the peptide formed Ag 
nanoparticles or high-aspect ratio nanowires as a function of immobilization 
concentration. 
Finally, we explored biomolecule-mediated formation of nanomaterials by 
investigating protein chimeras. We engineered and expressed proteins that included 
peptides known to bind silver or iron. The Ag and Fe binding peptide-based protein 
chimeras successfully demonstrated in vitro activity. Additionally the iron binding 
proteins were capable of scavenging trace iron from Luria-Bertaini broth during protein 
expression, creating nanoparticles in vivo. These results have lead toward developing 
genetically clonable tags, where specific proteins are labeled with a biomolecule 
capable of mediating the synthesis of a nanomaterial, and the unique nanomaterial is 
used to uniquely identify the protein of interest.  
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1. Chapter 1: Bio-mediated Materials 
1.1. Introduction 
1.1.1. Background 
Biomolecules have evolved in nature with the ability to synthesize materials with 
uniquely interesting properties in response to environmental stress. For example, the 
brittlestar (Figure 1.1A) has evolved fiber optic arms, which upon closer investigation 
(via electron microscopy) are coated in dome shaped calcium carbonate.3 These domes 
act as multiple light focusing lenses that send a signal to the brittlestar’s central nerve 
warning it of light exposure and possible predation. Another example of bio-adaptability 
is seen in magnetotactic bacteria which have evolved with the ability to migrate along 
geomagnetic fields to find optimal habitats by synthesizing iron oxide in vivo and 
forming a bar magnet (Figure 1.1B).4 In addition, butterflies and moths have wings 
coated with nano-nipple arrays that do not reflect light, allowing them to be less visible 
to predators (Figure 1.1C).5 This technology has recently been exploited for cell phone 
displays.6  
Solar-powered plant/mammal mutants have also been discovered. The green sea 
slug has been observed to use chloroplasts (obtained by consuming algae) to produce 
chlorophyll (Figure 1.2). 7 These sea slugs actually incorporate the algae’s genetic 
material into their own and are able to survive without food for long periods of time, as 
long as they are exposed to light for twelve hours per day. 
Figure 1.1. A) EM image of CaCO3 lenses and picture of brittle star B) 
Magnetotactic bacteria, inset is bar magnet formed in vivo, C) nano-nipple 
array. 
2 
Nature’s method of materials synthesis 
has several advantages over man-made 
materials synthesis technology. Natural 
materials can be formed under ambient 
conditions of temperature and pressure 
and near-neutral pH. The biological 
molecules that mediate the formation of 
natural materials often control the size, 
shape, crystallinity and function of the 
material in ways that currently cannot be 
achieved in vitro. Furthermore, nature is 
capable of making these elegant materials under environmentally friendly conditions 
from a limited number of biologically available metals (Zn2+, Ca2+, Fe2+, Mg2+, Si2+, 
Cu2+). 
The ability to control the size, shape and crystallinity of a material possessing long 
range order and uniquely pre-defined properties, while maintaining mild synthetic 
reaction conditions has eluded scientists. Efforts towards exploiting biomimetic 
processes have increased over the last ten years. However, mimicking natural materials 
synthesis requires not only the identification of a functional biomolecule, but also the 
ability of that biomolecule to mediate the formation of a material in vitro. In 1999, a 
protein (silicatein) was isolated from marine sponges that synthesized silica spicules (1-
2 mm wires).8 Silicatein was observed to direct the formation of silica in vitro.8 
Additionally, the functional moiety of silicatein has been identified and shown to have 
activity toward the formation of other oxide materials (TiO2).  Other groups have since 
isolated peptides and proteins from biological organisms that also function in vitro. For 
example, the Wright group has identified peptide mutants of the NatSilA protein (derived 
from C. fusiformis) capable of catalyzing the formation of silica and TiO2 in vitro.9 These 
efforts have demonstrated the ability of native proteins to mediate the formation of 
materials in vitro in addition to elucidating some mechanistic details of biomediated 
material synthesis.  
 
Figure 1.2. Green Sea Slug 
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1.1.2. Selected Evolution of ligands by exponential enrichment 
Biological molecules found in nature are capable of maintaining their native function 
in vitro, but can directed evolution of a biological molecule be employed in vitro? Can 
biological molecules be chosen with functions for non-biologically abundant metals?   
SELEX (systematic evolution of ligands by exponential enrichment) was originally 
developed as a combinatorial approach to evolving RNA (dideoxyribonucleic acid) or 
ssDNA (single stranded deoxyribonucleic acid) sequences as aptamers for target 
ligands (Scheme 1.1).10 The SELEX method takes advantage of a variety of enzymatic 
reactions allowing for a cyclical method of exposing biological molecules to a certain set 
of conditions, and separating ssDNA or RNA with a desired function from those that are 
inactive. A typical selection begins with a random library of ssDNA sequences (~ 1014) 
comprised of 40-100 random bases flanked by conserved regions used for future 
enzymatic reactions. This library is then amplified via two-cycle PCR (polymerase chain 
reaction) to create dsDNA (double stranded DNA). This dsDNA is then transcribed into 
RNA using T7 RNA polymerase to create a random pool of ~1014 different RNA 
Scheme 1.1 
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sequences. The random pool of RNA is then subjected to a selection pressure, i.e. 
binding to a particular target. Active RNA sequences are retained, and inactive 
sequences are partitioned away via affinity chromatography (for example). The resultant 
pool of active sequences is then reverse transcribed into cDNA (copy DNA) and 
amplified again so that round two of the selection can begin. The active RNA sequences 
collected after the selection is complete comprise an evolved pool of sequences 
capable of performing a desired function. Selection completion is determined by either 
identifying sequence convergence in the evolved pool via bulk sequencing or by 
achieving a steady state value of quantitated active RNA sequences.  The pool of 
evolved sequences are separated and uniquely identified from one another via 
molecular cloning and DNA sequencing. Individual DNA or RNA sequences are then 
tested for their function, and information can often be obtained about the structure-
function relationship of the RNA.  
SELEX has been modified to identify RNA sequences that mediate the formation of 
palladium hexagons and iron oxide nanoparticles (Figure 1.3A and B).11, 12 Because 
metals with specific sizes and/or properties were the desired product, the partitioning 
step was altered to eliminate any RNA sequence that did not have the desired function. 
In the case of the palladium hexagons, RNA sequences bound to anything smaller than 
100,000 kDa were discarded. However, in the synthesis of iron oxide nanoparticles, a 
Figure 1.3. A) TEM image of palladium hexagons synthesized by selected 
RNA sequence Pd17. B) TEM image of iron oxide nanoparticle synthesized 
from selected RNA sequence A5. 
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magnetic partitioning step was used to eliminate RNA’s bound to other (non-magnetic) 
Fe species formed in the aqueous reaction volume. These two examples were the first 
demonstrations of RNA-mediated materials synthesis of both metal and metal oxide 
nanoparticles.  
1.1.3. Phage Display Selections 
Phage display (Scheme 1.2) is another combinatorial method used to identify 
biomolecules with unique properties. Originally, phage display libraries were employed 
to identify protein-protein interactions. More recently phage have been used to identify 
peptides that bind to specific surfaces.13 A bacteriophage is a virus, which can express 
a peptide as a fusion with the viral coat protein of a phage. The DNA encoding for the 
displayed peptide is located within the phage virion, and can infect a bacterial cell and 
splice the “foreign” DNA into the bacterial genome.  A phage display selection (referred 
to as bio-panning) begins with a heterogeneous mix of phage clones (each clone having 
a different peptide sequence expressed on its surface). The peptide-coated viruses are 
then exposed to a material or surface of interest. Washing steps are then employed to 
remove any phage that do not bind the target of interest.13 Bound phage are then eluted 
Scheme 1.2 
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from the target material, yielding a smaller pool of heterogeneous phage clones. A key 
advantage of phage display is that the remaining pool of phage can be infected into and 
amplified in E. coli. The amplified pool of phage can then be introduced to a subsequent 
round of selection and the process is repeated until sequence homology is achieved. An 
additional advantage of phage display is the genotype/phenotype relationship, which 
facilitates rapid identification of binding phage clones.  
Interestingly, many of the peptides identified via phage display as aptamers for 
specific metals have also been observed to mediate the formation of materials in vitro 
from precursor materials. 14-17 Belcher et al. have identified peptides that bind to zero-
valent gold and silver, CoPt nanoparticles, and cobalt doped lithium nanowires using the 
phage display method. 18-20 Belcher et al. have been able to use phage expressing two 
different peptide sequences that then mediate the formation of different inorganic 
materials such as Co3O4 and Au-Co3O4. Belcher has used these phage to assemble 
hybrid inorganic nanoparticle/viral biofilms that function as highly efficient batteries.  
1.1.4. Materials Characterization 
Bio-mediated materials range in size from the millimeter to nanometer scale. While 
large (mm) materials are relatively easy to characterize, special methods are necessary 
to completely characterize nanoscale materials. UV-Visible spectroscopy enables 
limited materials characterization for nano-sized objects. Locating the plasmon 
resonance band within a UV-Visible spectrum offers information about the type and 
relative size of a material. However, precise information about the nano-material, such 
as morphology, elemental composition and size dispersity requires examination via 
other methods such as electron microscopy. 21 
 Electron microscopy, specifically transmission electron microscopy (TEM), is 
capable of imaging particles as small as ~ 2 nm in diameter. Electron microscopy 
techniques also can be equipped with a range of analytical instrumentation. Thus, 
electron microscopy facilitates imaging nano-scale materials size as well as  
morphology. Additionally, coupling TEM with elemental analysis techniques such as 
selected area electron diffraction (SAED), electron energy loss spectroscopy (EELS) 
and energy dispersive x-ray spectroscopy (EDS) provides additional information for the 
analysis of nanoscale materials.  
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1.1.5. Applications 
While current imaging technologies are capable of imaging diseased tissues such as 
blocked arteries and cancerous tissues, the cells that comprise such tissues and the 
atomic structure of protein assemblies located within these cells is currently difficult to 
access. That is, currently it is simply impossible to directly image protein-protein 
interactions inside of cells.  
Currently, whole cells can be imaged using a three-dimensional electron microscopy 
technique called electron tomography. The ability to image whole, intact cells in 
principle could provide the opportunity to observe intracellular interactions. While 
tomography allows the observation of intracellular materials, the individual intracellular 
proteins are indistinguishable from one another. Thus while proteins inside of cells can 
be observed in whole cell tomographic reconstructions, it is not yet possible to uniquely 
identify one biomolecule from another. What is needed to advance the field of cellular 
bioanalysis is an electron dense marker for electron tomography, analogous to 
biomarkers such as the green fluorescent protein that are available for fluorescence 
microscopy. In this respect, high contrast materials such as the noble metals (materials 
with a large atomic number or Z) are readily identifiable via TEM. It would thus be 
advantageous to develop a method of intracellular labeling with metal and/or metal 
oxide nanomaterials.  
Our goal has been to develop a new method of in vivo protein labeling that takes 
advantage of bio-mediated material synthesis. A genetically encoded bio-molecule tag 
capable of mediating the formation of high contrast nanomaterials exclusively at the site 
of interest in the cell would provide the ability to localize and identify proteins in vivo. 
Moreover, a set of unique biomolecule tags capable of generating nanoparticles that 
differ by either size, shape, or composition would allow the simultaneous localization 
and identification of multiple proteins in a single experiment.  
1.1.6. Summary 
Materials design is complicated. It is very difficult to build a material with specific and 
unique properties simply by mixing together metals from the periodic table. The possible 
combinations are effectively infinite, the correct or desired combination could take years 
to identify. A traditional combinatorial approach to mixed-metal materials synthesis 
8 
could yield useful materials such as methanol oxidation catalysts; however, it could take 
years in a laboratory to discover such a material. Employing biomolecules and 
mimicking natural selection could provide a rapid alternative method of materials 
discovery.  
While bio-mediated materials synthesis is a good method for designing and 
obtaining materials with unique properties, the mode of action is still poorly understood 
in most cases. As part of this thesis, in addition to investigating biomolecules capable of 
synthesizing inorganic materials, the sequence-function relationship of the selected 
RNAs, peptides and proteins was also studied. Identification of important amino acids, 
folding patterns, and binding affinity are essential to truly understanding bio-mediated 
materials synthesis. This thesis is a first step toward building that understanding. 
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2. Chapter 2: In vitro selection of RNA sequences that mediate the formation of iron 
oxide nanoparticles 
2.1. Introduction 
The extraordinary materials found in our biosphere have inspired a growing 
research effort in which biomolecules are used to synthesize and assemble materials in 
the laboratory.1, 2 Peptides 3-6, nucleotides, RNA 1, DNA7-11, and proteins 12, 13 have all 
been shown to be capable of mediating the formation of nanoscale materials with 
atypical morphologies, crystal structures, and sizes that have resulted in some 
instances in unexpected properties14. In addition to potentially affording more 
environmentally friendly routes to novel inorganic materials, the highly selective 
recognition capabilities of biomolecules are proving to be useful in the assembly of 
nanoscale materials into more complex functional assemblies and devices. 15, 16 
A variety of methods exist for discovering biomolecules that can mediate the 
formation of a nanoscale material. They range from rational design, in which a single 
sequence is chosen to mimic a biomolecule found in nature12, to microarrays in which 
hundreds (and in principle millions) of sequences are tested simultaneously17, to 
directed evolution/selection approaches that sample vast sequences (up to 1015) during 
the course of a single experiment.1, 9 The rational design approach has provided new 
information on the mechanisms of natural biomineralization processes.18, 19 Microarray 
and in vitro selection techniques are of interest because an enormous biomolecule 
sequence and structure space is sampled, and groups of related (and unrelated) 
sequences typically emerge that can further identify interesting sequence-function 
relationships20.  
The following demonstrates that RNA sequences capable of mediating the 
formation of metal oxide nanoparticles can be isolated from iterative cycles of in vitro 
selection and amplification. Sequences isolated from this selection were able to mediate 
the formation of iron oxide nanoparticles at neutral pH and room temperature. 
 
12 
2.2. Results and Discussion 
2.2.1. The Selection 
To probe the ability of RNA to mediate the formation of metal oxides, in vitro 
selection was performed as depicted in Figure 2.1. (This selection was performed as 
part of a previous dissertation thesis).21 The selection began with a chemically 
synthesized (ABI 391) library of ~1014
 
unique ssDNA sequences, 87 bp in length, 
containing a center region of 40 bp, random in sequence. PCR was used to generate a 
dsDNA library. In step 1, T7 RNA polymerase was used to transcribe the dsDNA library 
into a ssRNA library containing ca. 1014
 
sequences. During transcription, native UTP 
was replaced with 5-(4-imidazolylmethyl)-UTP.22 This modification was incorporated to 
provide additional functionality for metal coordination and proton transfer beyond that 
provided by the native nucleotides.22, 23 
In step 2, the RNA library (900 nM) was incubated for 5 hours at ambient 
temperature with the metal salts CoCl2 and FeCl2 (37.5 µM and 150 µM, respectively) in 
buffer (100 mM NaCl, 
100 mM KCl, 50 mM 
HEPES, pH 7). Co 
and Fe were chosen 
to allow for a range of 
possible compounds 
to be formed including 
pure iron phases, Co-
doped iron oxides, 
and CoFe2O4. RNA 
sequences that were 
involved in the 
formation of 
nanoparticles were 
separated from 
inactive RNA and 
unused reagents in step 3 using magnetic field partitioning. A vial containing incubated 
Figure 2.1. Illustration of the RNA in vitro selection cycle 
used to discover sequences capable of mediating the 
formation of magnetic nanoparticles. UTP* represents 5-
(4-imidazolylmethyl)-UTP. RNAs and nanoparticles are not 
drawn to scale. 
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material was placed on a permanent magnet (ceramic coated neodymium, 35 mm x 25 
mm x 5 mm, N35) for 12 hours. Magnetic nanoparticles with bound RNA were attracted 
by the magnet and remained in the tube while the reaction solution was removed from 
the vial. The vial was washed 4 times (200 mL of 1 mM NaCl, 1 mM KCl, 1 mM Na2PO4 
at pH 7) while still on the magnet.  Upon removal of the vial from the magnet the 
retained RNA pool and the associated inorganic material was resuspended in 100 µL of 
H2O. The selected RNA pool was reverse transcribed (step 4) to give a cDNA copy of 
each retained RNA sequence. PCR amplification completed the selection cycle and 
provided a dsDNA template enriched in the selected sequences and ready for T7 RNA 
polymerase transcription and the beginning of the next cycle. 
2.2.2. Characterization 
2.2.2.1. The Evolved Pool 
The materials 
synthesized in the 
presence of RNA were 
characterized by 
performing transmission 
electron microscopy (TEM; 
Philips CM12, 100 kV) on 
the magnet-partitioned 
product from the cycle 8 
RNA pool. (Cycle 8 was 
chosen because it showed 
a relatively large increase 
in the % RNA retained 
compared to cycles 6 and 
7; 2 % vs. 0.04 % and 0.06 
%, respectively.) Samples 
prepared by drop-casting 
the solution onto carbon-
coated formvar TEM grids 
Figure 2.2. (Top) Electron microscope image of 
material isolated following incubation of the cycle 8 
RNA pool with FeCl2 and CoCl2 and magnetic field 
partitioning. Sample was drop-cast on a carbon-coated 
formvar grid. (Bottom) Average particle size was 9.7 nm 
± 10 nm. 
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revealed spherical nanoparticles 9.7 nm ± 10 nm in diameter (Figure 2.2). Control 
experiments in which Co2+ and Fe2+
 
were incubated in HEPES buffer without RNA, 
partitioned in the magnetic field, and drop-cast onto TEM grids yielded only a few 
aggregated structures as observed by TEM (Figure 2.3).  
The cycle 8 RNA pool was then cloned and sequenced. Representative 
sequences identified are shown in Figure 2.4.  A surprising result was the over 
representation (ca. 40 %) of the modified U in many of the isolated sequences.  The 
lack of highly conserved sequence motifs (7-mer) was also curious and prompted us to 
investigate the magnetic partitioning step of the selection for these sequences.  
2.2.2.2.  % RNA resuspended 
 
Figure 2.3. Examples of rare structures observed by TEM in FeCl2, 
CoCl2, HEPES, KCl, and NaCl solutions (without RNA) and magnet 
partitioned. Sample was drop-cast on carbon-coated formvar. 
 
Figure 2.4. Imidazole-modified RNA sequences isolated following 8 cycles of the selection 
illustrated in Figure 1. Shown in color is a short semi-conserved sequence region. Fixed 
sequence regions were omitted for clarity. 
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 The data in Table 2.1 compare the % RNA resuspended following incubation 
and partitioning in the presence and absence of the magnetic field. The % RNA 
resuspended is defined as 100 (mols RNA recovered following magnet partitioning/mols 
input into the incubation solution) and was determined by liquid scintillation counting. 
Values are listed for sequence I2-96, I2-96 transcribed with native UTP in place of 
imidazole-modified UTP, and the initial random sequence imidazole-modified RNA 
library. Statistical analysis using Student’s T test revealed that the % of sequence I2-96 
resuspended following magnetic field partitioning was significantly larger compared to 
partitioning performed without the field. No statistically significant difference in % RNA 
resuspended with and without the field was found for the random sequence library or I2-
96 transcribed with native UTP. These data suggest that RNA I2-96 emerged from the 
selection as a sequence that mediates the formation of material that is retained by the 
magnet in relatively large quantities during partitioning compared to the initial RNA 
library. A majority of the sequences in the random RNA library are presumed to be 
incapable of mediating the formation of material that responds to a magnetic field. 
Furthermore, as suggested by its abundance in the selected sequences, the presence 
of modified U in I2-96 appears to be important to the recovery of material by magnet 
partitioning. 
2.2.2.3. Gel Shift Analysis of magnet partitioned material bound to RNA 
Incubations of RNA isolate I2-96 containing both FeCl2 and CoCl2, no metals, or 
FeCl2 only were analyzed via 6% native PAGE. The hypothesis was that RNAs 
associated with high molecular weight material would migrate at a slower rate than 
Table 2.1. % RNA resuspended following metal ion incubation and partitioning with and 
without the magnetic field. I2-96 and random library are based upon 4 trials for each 
experiment, I2-96 with native U values are from 3 trials for each experiment. 
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native RNA. The incubations were performed at room temperature for 100 minutes, and 
then placed at 4°C overnight either in the presence of a magnetic field or not. 
Incubations held in the magnetic field overnight were washed with 3x200 µL H2O in the 
presence of the magnet, then removed from the magnetic field and resuspended in 20 
µL H2O. The 20 µL resuspension was loaded directly onto the gel.  The non-magnet 
partitioned incubations were not washed; rather a 20 µL aliquot of the incubation was 
loaded directly onto the gel. Figure 2.5 shows the resultant gel image where 
radiolabeled RNA is observed in two places. The red box indicates RNA that migrated 
quickly, while the yellow box indicates 
radiolabeled RNA that migrated at a 
slower rate.  Lanes A and B show the gel 
shifts from incubations containing isolate 
I2-96, FeCl2 and CoCl2, however, the 
incubation in lane A was magnet 
partitioned while the material in lane B 
was not partitioned. In each of these 
lanes, it appears as though the majority 
of the radiolabeled RNA is associated 
with high molecular weight material. 
Resuspensions of I2-96 and FeCl2 were 
run in lanes C and D; there is a gel shift 
observed in each lane. However, lane D 
contains a qualitatively larger amount of 
quickly migrating (unbound) RNA, which 
indicates that not all of the input RNA is 
associated with high molecular weight 
material. This result supports the observations of the RNA resuspension experiments 
(section 2.2.2.2) where only a percentage of the input RNA is resuspended after magnet 
partitioning. Comparing lane C (magnet partitioned) to lane D (not partitioned) indicates 
that magnet partitioning results in high molecular weight material being carried through, 
while inactive or non-binding RNA sequences are discarded. Most notably, incubations 
Figure 2.5. 6% native PAGE image of 
radiolabeled RNA sequence I2-96 with A) 
FeCl2 and CoCl2, magnet partitioned B) 
FeCl2 and CoCl2, not partitioned C) FeCl2 
only, magnet partitioned D) FeCl2 only, 
not partitioned E) no metals, magnet 
partitioned and F) no metals, not 
partitioned.  
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E (magnet partitioned) and F (no partitioning) contained no metals and clearly no gel 
shift was observed, whereas all of the other lanes demonstrated an obvious gel shift.   
2.2.2.4. XPS and ICP-MS 
Nanoparticles synthesized in the presence of sequence I2-96 were then 
characterized by X-ray photoelectron spectroscopy (XPS) and inductively coupled 
plasma-mass spectrometry (ICP-MS). XPS detected Fe in 3 of 3 samples tested (bands 
at 710.2 eV and 723.7 eV, referenced to the C 1s band)24 and Co in 1 of 3 samples 
tested (782.5 eV) (Figure 2.6). We note that these samples were sputtered with 5 keV of 
Ar+ ions for ca. 30 min to remove impurities and obtain the strongest Fe and Co signals. 
Ion bombardment has been shown to cause reduction of iron oxides to FeO, and thus 
cannot be used to determine the phase of an iron oxide or hydroxide that may have 
been present prior to analysis.24 The data presented here are intended only to verify the 
presence of Fe and Co. ICP-MS confirmed the presence of Fe and Co and quantified 
the average mass ratio as 28 ± 9 Fe:1 Co (avg. of 4 samples). ICP-MS further showed 
that the total mass of Fe recovered from solutions containing sequence I2-96 was 
roughly 4 orders-of-magnitude larger than solutions incubated without I2-96 when both 
solutions were partitioned with the magnetic field (4.5 mg/mL ± 3.4 mg/mL Fe in 4 
samples with I2-96 and values close to the detection limit of ca. 5 ng without I2-96). The 
source of the high batch-to-batch variability in these measurements is likely due to 
inconsistencies inherent in the magnetic field partitioning step. 
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Collectively, the TEM, XPS, % RNA resuspended, gel shift, and ICP-MS data 
suggested to us that mixed cobalt and iron-containing nanoparticles were isolated via a 
process that depended upon RNA sequence and magnetic field partitioning. However, 
the synthesis of iron oxide and hydroxide nanoparticles from aqueous solutions of 
ferrous and ferric salts is extremely complex. The phase, size, and morphology of 
nanoparticles obtained depends upon Fe concentration, pH, pO2, temperature, solution 
ionic strength, counter ion, and time.25 Additional experiments were thus performed to 
clarify the role of RNA and buffer on nanoparticle formation, beginning with the simple 
visual inspection of the incubation solutions (i.e., not magnet partitioned). Solutions of 
CoCl2 and FeCl2 that were aged for 12 hrs in HEPES buffer in the absence of RNA were 
Figure 2.6. X-Ray photoelectron spectrum of nanoparticles synthesized in the 
presence of RNA sequence I2-96. The sample was sputtered with 5 keV of Ar+ 
ions for 30 min to remove impurities. 
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observed to turn from colorless to dark yellow (Figure 2.7). If left unperturbed, a yellow 
“concentrate” was observed to settle to the bottom of the tube (e.g., the consistency of a 
liquid but yellow in color). The yellow substance was not magnet responsive, and when 
collected by centrifugation and analyzed by powder X-ray diffraction, the material 
proved to be amorphous. Identical solutions that contained RNA turned only slightly 
yellow and did not produce the concentrate, supporting the hypothesis that RNA directly 
affects the fate of the Fe in solution. The role of HEPES in the colorless to yellow 
transformation was examined by replacing it with phosphate-buffered saline (PBS). 
CoCl2 and FeCl2 aged for 12 hrs in PBS turned only a faint yellow, and again the 
presence of RNA qualitatively decreased the intensity of the yellow color (Figure 2.7).  
2.2.2.5. Cryo-EM 
In order to better understand the fate of Fe in these solutions, samples prepared 
from PBS solutions were examined by cryoelectron microscopy (cryo-EM). This 
technique, in which the solution phase sample is rapidly frozen (vitrified) and examined 
at liquid-nitrogen temperatures in its “frozen hydrated” form, provides a genuine 
snapshot of the solution in which the particles are suspended. Compared to the method 
of drop-casting nanoparticle samples onto TEM grids, cryo-EM removes concerns that 
the observed particles may form during the drying process or that the particles may be 
Figure 2.7. Photographs of aqueous solutions containing 150 µM FeCl2, 37.5 µM 
CoCl2 and (A) RNA sequence I2-96, PBS buffer, NaCl, and KCl (B) PBS buffer, 
NaCl, and KCl without I2-96, (C) I2-96, NaCl, KCl, and HEPES, (D) NaCl, KCl and 
HEPES without I2-96, and (E) FeCl2 and CoCl2 only. The concentrations used were 
0.9 µM RNA, 1X PBS, 50 mM HEPES and 100 mM each NaCl and KCl. All 
solutions were aged for 12 hrs. 
A B C D E 
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modified from their solution crystalline form by dehydration. It also minimizes concern 
about material being modified by the electron beam. To emphasize the final point we 
note that the materials examined were exposed to 10 e-/Å2 or less, which is a dose that 
is known to leave even protein structures essentially intact.  
Cryo-EM images of vitrified solutions of FeCl2, CoCl2, and PBS prepared with 
and without sequence I2-96 are shown in Figure 2.8. Clear differences were observed 
between the two samples. The latter solution contained a preponderance of 
comparatively large and morphologically ill-defined particles, but very few smaller (e.g. 
10 nm diameter) spherical particles (Figure 2.8A). In contrast, the former solution 
contained an abundance of spherical nanoparticles identical in diameter (8.0 nm ± 2.9 
nm; 100 particles) to those observed for nanoparticles prepared with I2-96 in HEPES 
buffer. While the average diameter was also similar to that found for nanoparticles 
synthesized in the presence of the cycle 8 RNA pool, the size distribution was much 
larger for the cycle 8 pool compared to sequence I2-96. This may be due to variations in 
nucleation and/or growth rates of particles formed in the presence of the different 
sequences contained within the cycle 8 pool. In addition, the nanoparticles shown in 
Figure 2.8B were crystalline as assessed by cryo-electron diffraction (Figure 2.8C). The 
diffraction pattern suggested that the material was unlikely to be the iron minerals 
Figure 2.8. Cryo-EM images of 1X PBS solutions containing 100 mM NaCl and 
KCl, 37.5 µM CoCl2, 150 µM FeCl2 and incubated (A) without RNA, and (B) with 0.9 
µM RNA sequence I2-96 (B). Scale bars are 25 nm. (C) Electron diffraction pattern 
obtained from particles shown in (B). Both solutions were aged for 12 hrs. Rings 1-5 
in (C) correspond to d-spacings of 3.40 Å, 2.09 Å, 1.77 Å, 1.37 Å, and 1.20 Å, 
respectively.  
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hematite (a-Fe2O3), 2 or 6 line ferrihydrite, lepidocrocite (g-FeOOH), goethite (a-
FeOOH) and akaganeite (b-FeOOH), but was more likely magnetite (Fe3O4)/maghemite 
(g-Fe2O3) (3.40 Å/(211), 2.09 Å/(400), 1.77 Å/(422), 1.37 Å/(620), and 1.20 Å/(444)). 
The material found in the no-RNA control solution (Figure 7A) did not diffract electrons. 
An additional control solution consisting of a 47-base RNA sequence containing 25 % 
modified U, FeCl2, CoCl2, and PBS was prepared and vitrified. This solution failed to 
yield nanoparticles when examined by cryo-EM. 
2.2.2.6. Aqueous Iron Chemistry  
To interpret the results presented above it is instructive to review briefly the 
chemistry of aqueous iron. In order to precipitate any solid metal oxide or hydroxide 
phase a hydroxylated monomeric metal complex species must first be generated.26-36 
The speciation of ferrous salts in aqueous solution is such that below pH 7 and in 
anaerobic environments iron exists as the hexa-aquo complex [Fe(H2O)6]2+.  Above pH 
7 [Fe(H2O)6]2+ is converted to the hydroxylated form [Fe(H2O)4(OH)2]0, which ultimately 
precipitates as Fe(OH)2.35 In aerobic environments, [Fe(H2O)6]2+ is oxidized to the 
corresponding ferric complex, which at pH > 2 is followed by deprotonation to again 
yield hydroxylated species [Fe(H2O)6-xOHx](3-x)+ (x increasing with pH). The OH ligand in 
either the ferrous or ferric species is a nucleophile that initiates a substitution reaction 
involving any remaining divalent hexa-aquo ions or another trivalent aquo-hydroxy 
complex. This reaction is referred to as olation: 
In aerobic environments, olation leads to short oxyhydroxide chains or clusters 
frequently described as ferric gels, polymers, or ferrihydrites. Ferrihydrite polymers have 
been characterized in their condensed form as being largely amorphous, with local 
order similar to goethite (a-FeOOH) and akaganeite (b-FeOOH).  
 Olation can be followed by proton transfer from an ol bridge to a terminal OH 
ligand to form an oxo bridge (oxolation): 
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This dehydration reaction leads to the iron oxides, but the rate and resulting 
phase depends upon pH, iron concentration, ionic strength, and temperature. 
Temperature and pH (or both) are most frequently used to accelerate the dehydration of 
ferrihydrites to produce iron oxides. At pH > 9, for instance, the co-precipitation of 
Fe2+/Fe3+ favors the formation of magnetite. At room temperature and neutral pH, the 
conditions of the experiments reported here, ferrihydrite has been reported to convert to 
the iron oxide hematite with a half-life of over 100 days.24  
Based upon its color in solution, amorphous structure, and ill-defined morphology 
as observed by TEM, the yellow material formed in the absence of RNA is reminiscent 
of the ferrihydrite polymers. In the presence of the selected RNA sequences the iron 
ions input into the incubation solutions appear to be converted to crystalline, spherical 
nanoparticles of magnetite/maghemite with Co2+ present in small amounts. While the 
mechanistic details for the formation of the cobalt iron oxide nanoparticles observed to 
form in the presence of RNA remain to be elucidated, these chemical considerations 
suggest a direct role for RNA in accelerating ferrihydrite condensation and oxolation.  
2.3. Conclusions 
In summary, several important conclusions can be drawn from this work: (1) The 
selected RNA sequences appear to influence the formation of magnet-responsive 
spherical nanoparticles ca. 8 nm in diameter; (2) Clear differences in the size, 
morphology, and crystallinity of material formed from Co2+/Fe2+ solutions in the 
presence vs. absence of RNA isolate I2-96 were observed; (3) The synthesis of what 
we will conservatively call—due to the inherent ambiguities in characterizing mineralized 
iron phases—Co-doped Fe oxide, occurs on a more rapid timescale than is typical 
under these conditions of temperature and pH; and (4) The RNA selection step was 
based upon a materials property (magnetic responsiveness). Property based 
partitioning methods could serve to broaden the scope of materials in vitro selection 
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experiments, enabling the isolation of new materials by rapidly sampling a large 
biomolecule sequence space.  
2.4. Experimental 
2.4.1. Reagents 
All reagents were used without further purification. Milli-Q water was treated with 
diethylpyrocarbonate (depc) prior to use to ensure nuclease- and protease-free water. 
2.4.2. Methods 
PCR amplification of DNA Templates 
5′-primer (5′-TAATACGACTCAC-TATAGGGAGACAAGAATAAACGCTCAA-3′) 
and 3′-primer (5′-GCCTGTTGT-GAGCCTCCTGTCGAA-3′) were purchased from 
Midland Certified, Inc. 2 nM dsDNA template were combined with 1X Taq DNA 
Polymerase buffer (New England Biolabs, 10 mM KCl, 10 mM (NH4)2SO4, 20 mM Tris-
HCl, pH 8.8, 2 mM MgSO4, 0.1% Triton X-100), 0.12 mM each of dATP, dCTP, dGTP, 
and dTTP, 1 µM each of 5′-primer and 3′-primer, and 0.1 U/µL Taq DNA Polymerase 
(New England Biolabs). PCR was performed using the following reaction parameters: 
95 °C, 2 minutes; followed by multiple cycles of 95 °C, 30 seconds, 60 °C, 30 seconds, 
72 °C, 45 seconds; hold at 4 °C. The dsDNA was purified using QIAquick PCR 
Purification Kit (Qiagen) and quantitated via UV-Vis spectroscopy. 
RNA Synthesis 
RNA was prepared by transcription of dsDNA templates. For example, the initial 
random sequence RNA library was prepared with 5X T7 RNA Polymerase buffer 
(homemade or from Promega) (4% (w/v) PEG 8000, 40 mM Tris-HCl, pH 8.0, 12 mM 
MgCl2, 5 mM dithiothreitol (DTT), 1 mM spermidine HCl, 0.002% Triton X-100), 0.2 mM 
each of ATP, CTP, GTP, and 5-(4-imidizolylmethyl)-UTP, 250 nM dsDNA template, 125 
nM T7 RNA Polymerase (Promega), 0.8 U/µL RNase inhibitor (Promega) incubated at 
37 °C for 6 hours to yield imidazolyl modified RNA transcript, 87 bases long: 5’-
GGGAGACAAGAATAAACGCTCGG-[40N]-TTCGACAGGAGGCTCACAACAGGC-3’. 
[α-32P]-ATP body-labeled RNA was generated using an identical protocol with the 
addition of 30 µCi of [α-32P]-ATP per reaction. Size-exclusion membranes (Microcon 10, 
10-kD cutoff) were used to separate the full-length RNA from the reaction buffer and 
any unincorporated NTPs. The reaction mixture was first concentrated onto the 
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membranes by centrifugation and washed four times with buffer containing NaCl (1 
mM), KCl (1 mM), and Na3PO4 (1 mM, pH 7.2). The purified RNA was recovered from 
the membranes by resuspension in 50-100 µL of water. The RNA was purified 
additionally with 6% denaturing PAGE. 
Experiments involving RNA quantitation (e.g., % resuspension) were performed 
using radiolabeled RNA and liquid scintillation counting using a Beckman Coulter LS-
6500.  
Nanoparticle Synthesis 
Sample preparation. RNA (0.9 µM) was incubated in the presence of 150 µM FeCl2 
(Acros), 37.5 µM CoCl2 (Riedel-de Hasen), 100 mM NaCl (Riedel-de Hasen), 100 mM 
KCl (Riedel-de Hasen), 50 mM HEPES (Fisher BioReagents) or PBS (136 mM NaCl, 
2.68 mM KCl, 10.14 mM Na2HPO4 (Sigma), 1.51 mM KH2PO4 (Sigma)) pH 7.3. 
CoCl2/FeCl2 salts were dissolved in RNase free Mili-Q water to give a concentration of 1 
mM and 0.5 mM respectively, followed by degassing with Ar for at least 15 minutes to 
remove oxygen. The CoCl2/FeCl2 solutions were added to the RNA/salt solution 
(unpurged) to yield the final concentrations. Following the incubation, the reaction 
mixture was transferred to a new tube prior to magnetic field partitioning to eliminate 
any RNA bound to the sides of the eppendorf tube. Magnetic field partitioning was 
performed by placing the eppindorf tube containing incubated material on a permanent 
magnet (ceramic coated neodymium, 35 mm x 25 mm x 5 mm, N35) for 12 hours. 
Magnetic nanoparticles with bound RNA were attracted by the magnet and remained in 
the tube while the solution was completely removed. The particles that remained in the 
tube were then washed 4 times in the presence of the magnet with 200 µL of 1x buffer 
(K+, Na+, PO43-) and resuspended in 100 µL of dH2O. 
The RNA sequence used in 47-base control experiment was 
GGGAGAAAUACAAAU AGGCAGGAUUCGACAGGAGGCUCACAACAGGC. 
Reverse Transcription 
RNA retained by magnet partitioning was combined with 0.5X 1st Strand Buffer 
(50 mM Tris-HCl, pH 8.3, 75 mM KCl, and 3 mM MgCl2), 0.5 mM each of dATP, dCTP, 
dGTP and dTTP, 2 µM 3′ primer, and 0.4 U/µL AMV Reverse Transcriptase (New 
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England Biolabs). The RNA was reverse transcribed at 42 °C for 45 minutes. Following 
reverse transcription, the enzyme was inactivated by heating at 72 °C for 15 minutes.  
X-Ray Photoelectron Spectroscopy (XPS) 
XPS analysis was performed using a Riber LAS-3000. Samples were analyzed 
by excitation of specimen with soft X-rays (source Mg anode, 1254 eV) followed by 
energy analysis of resulting photoelectron emission. To generate sufficient amount of 
colloidal material the incubation needed to be scaled up 200x. This required 
synthesizing ca. 3 mg of RNA. To generate this quantity of RNA, a Megascript High 
Yield Transcription Kit was used. Nanoparticle synthesis was then performed in ten 
separate 10 mL incubation reactions. The product was then separated from unused 
reactants and washed 3x with deionized water on 50K molecular weight cut off filters 
(Centricon 50), followed by magnetic field partitioning. XPS samples were prepared by 
evaporating small drops of magnetic material onto a silicon wafer. 
Inductively Coupled Plasma Mass Spectrometry (ICP-MS) 
ICP-MS analysis was performed by West Coast Analytical Service.  
Cloning and Sequencing 
Cloning was performed using protocols outlined by Stratagene as part of the 
PCR-ScriptTM Amp Cloning Kit including XL-10 Gold Kan ® Ultracompetent Cells. 
Alkaline Lysis and DNA purification was performed on a Qiagen Bio Robot 9600. Cycle 
Sequencing was done using the BigDye Terminator kit (Applied BioSystems). 
Sequencing was performed on an ABI 3700. 
Electron Cryo-Microscopy 
5 µl of samples containing each sample were placed on glow discharged R2/2 
Quantifoil TEM grids (Electron Microscopy Sciences) and were subsequently vitrified 
with liquid ethane in an automated plunge freezing apparatus (Vitrobot, FEI, Eindhoven, 
Netherlands) Blot time was 2.0 seconds, blot force 0, drain time 0.0 seconds, 
temperature 18 °C, humidity 95 C°. Samples were then imaged by electron cryo-
microscopy in an FEI F20 transmission electron microscope in a Gatan 626 cryoholder 
and operating at 200kV accelerating voltage. Images were collected on a 4k x 4k CCD, 
with 15µ pixel size.  Electron diffraction patterns were collected on the same instrument 
at 200 kV acceleration voltage, with a nominal reported camera length of 730 mm.  
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To obtain an exact camera length for indexing the experimental electron 
diffraction data, a diffraction pattern was obtained from a gridbar of the specimen grid 
containing the experimental sample. The gridbar diffraction indexed to elemental 
copper, allowing the assignment of a camera constant to the experimental data, which 
was collected with identical objective and C2 lens settings.  
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3. Chapter 3: Peptide Mediated Material Synthesis 
3.1. Introduction 
One of the primary objectives of this dissertation work was to exploit 
biomineralization in the assembly of two or more chemically distinct nanoparticle 
materials in predetermined locations either on a surface or inside a living cell for 
applications in nanoscale patterning and intracellular imaging. In pursuing these goals it 
was important to develop an understanding of the fundamental interactions between 
biomolecules and metal precursors during the nanoparticle synthesis process. 
Specifically, the experiments conducted were aimed at identifying the key residues in 
the biomolecule, the specificity of the biomolecule toward metal precursors, any specific 
structural motifs important to nanoparticle synthesis, and any key interactions of the 
peptide with the metal precursor.  
During the course of this study, a peptide (SLKMPHWPHLLP) was discovered with 
an unusual reactivity in the conversion of Ag+ to Ag nanoparticles. The reaction required 
the presence of Ag+, HEPES buffer, light, and peptide to occur. The absence of any one 
of these components compromised nanoparticle formation. These results are discussed 
within the context of changes in the Ag+ reduction potential upon coordination to the 
peptide and the photodecomposition of HEPES. In addition, the individual amino acids 
identified to be key residues (Trp and His) were examined for their ability to mediate the 
synthesis of nanoparticles under identical conditions to the native peptide. Comparing 
the function of Ge8 to two other peptides further elucidated the mechanism of 
nanoparticle formation. One peptide was a completely random sequence, the other was 
comprised of the same 12 amino acids as observed in Ge8 but in a random order. 
These studies showed that primary sequence, in addition to specific amino acids were 
required for Ag nanoparticle formation.   
Furthermore, as one of our primary objectives was to isolate peptides that mediate 
solid-state reactions when immobilized, the peptide was deposited onto TEM grids and 
assayed for activity. Incubation of peptide-coated TEM grids in a solution of Ag+ and 
HEPES showed that the immobilized peptide was active toward Ag nanoparticle 
formation. Surprisingly, depending upon the immobilization conditions, spherical 
particles or high aspect ratio wires that appeared to grow out from the points of 
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triangular Ag particles were observed to form. The unusual reactivity of this peptide 
further illustrates the range of solid-state chemical processes that biomolecules can 
influence. 
3.2. Results and Discussion  
3.2.1. Reactivity and Selectivity 
The peptide of interest in this work was SLKMPHWPHLLP, which was originally 
isolated from a phage library by Sandhage and coworkers8 based upon its ability to bind 
tightly to germania. The peptide, named Ge8, was also reported to catalyze the 
formation of germania networks when incubated with tetramethoxygermanium in 
methanol. Given the presence of a strong reducing agent (tryptophan), metal ion 
coordination and general acid/base catalysis site (histidine), and common metal 
nanoparticle capping agent (amine of lysine), we decided to investigate the reactivity and 
selectivity of Ge8 in the formation of a variety of metal and metal oxide nanoparticles. 
The catalytic activity of Ge8 toward metal oxide nanoparticle formation was investigated 
first with the metal precursors Zn2+, Zr2+, Ga2+, Ti4+, and Ge2+. All metals were incubated 
in concentrations ranging from 10 mM – 100 mM with 690 µM Ge8 at room temperature. 
The experiments were repeated in acetone, methanol, and water. A range of buffers 
were explored for experiments in which water was the solvent: pH 7.3 HEPES buffer, pH 
7.1 1X PBS buffer, pH 7.5 TBS buffer, and pH 7.5 Tris buffer. Only Ge2+ in methanol was 
observed to yield a precipitate in solution and solid network structures by TEM (identical 
in appearance to the material reported by Sandhage).  
The reactivity of Ge8 with Au and Ag salts was then investigated. Incubation of 
690 µM Ge8 with AgNO3 or HAuCl4 (at concentrations between 10 mM – 500 mM) in 
milliQ 18 MΩ H2O at room temperature for 48 hrs did not result in Ag or Au nanoparticle 
formation as observed by visible spectroscopy and transmission electron microscopy 
(TEM). HEPES was then included in the reaction solution. HEPES was chosen because 
it is known to act as a reducing agent in the formation of peptide-capped Au 
nanoparticles.13 However, incubation of 100 mM HAuCl4 with 690 µM Ge8 and 500 mM 
HEPES at room temperature resulted in the immediate formation of a massive black 
precipitate. When investigated by TEM, polydisperse micron-sized materials with 
irregular morphologies were observed.  
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In contrast to the behavior of Ge8 and Au, solutions containing Ge8, HEPES, and 
Ag+ turned from clear and colorless to a faint orange color over the course of 24 hrs. 
Visible spectroscopy revealed a broad absorbance centered at 460 nm, which was 
attributed to the Ag nanoparticle dipolar plasmon resonance (Figure 3.1). TEM showed 
that the solutions contained spherical particles 4.1 nm ± 0.9 nm in diameter (Figure 3.1). 
3.2.2. Mechanistic Studies 
3.2.2.1. The Role of Light 
The role of light in the production of Ag nanoparticles with HEPES and Ge8 was 
then explored. Light is known to cause the spontaneous reduction of Ag+ in solution 
even in the absence of buffers and peptides. Solutions containing 10 mM AgNO3 and 
100 mM HEPES, and exposed to light for 24 hrs did not yield the characteristic plasmon 
band of Ag nanoparticles (e.g., that shown in Figure 3.1). Moreover, when solutions 
containing Ge8, AgNO3, and HEPES were kept in the dark, nanoparticle formation was 
not observed over the course of 120 hrs. Thus, in this unusual reaction, the presence of 
light, HEPES, and Ge8 are required to convert Ag+ to Ag nanoparticles.  
3.2.2.2. Electrochemical Studies and Single Point Mutagenasis 
Electrochemical studies were performed to determine the effect of the peptide on the 
Ag+ reduction potential. Belcher has suggested that a glutamate hexamer (E6) lowers 
Figure 3.1. UV-visible spectrum and TEM image of Ag particles formed in a 
solution containing 690 µM Ge8, 10 mM AgNO3 and 100 mM HEPES, 
exposed to ambient light and room temperature for 24 hrs.  
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the reduction potential of Ag+, enabling the rapid and photoinduced production of Ag 
nanoparticles.14 Cyclic voltammetry of HEPES solutions containing E6 and Ag+ revealed 
no difference in the Ag+/Ag0 redox potential vs. solutions not containing E6. Solutions 
containing Ag+ and Ge8, however, showed that Ag+ cannot be reduced in a potential 
window of +0.8 V to –0.4 V (vs. Ag+/AgCl) for Ag+:Ge8 ratios less than 3:1 (Figure 3.2). 
For ratios greater than 3:1 (4:1, 5:1….10:1), Ag+/Ag0 redox was observed to occur at a 
potential identical to that of the Ag+/Ag0 redox couple in HEPES buffer prepared without 
Ge8. This suggests that Ge8 binds to Ag+ in a 3:1 ratio and renders Ag+ reduction 
energetically more difficult. Control experiments were performed to ensure that the lack 
of redox activity was not due to non-specific adsorption of Ge8 onto the electrode 
surface, blocking silver ions from being detected by the electrode. A cyclic 
voltammogram of K3Fe(CN)6 was performed prior to and following a 5-minute incubation 
of the electrode in a solution of peptide. No measurable difference was observed in the 
Figure 3.2. Cyclic voltammograms of solutions containing 690 µM Ge8, 100 mM 
HEPES and A) 1, 2 and 3 molar equivalents of AgNO3:Ge8 and B) 4 molar 
equivalents of AgNO3. Working, auxiliary, and counter electrodes were glassy 
carbon, Pt, and Ag/AgCl, respectively. 
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two cyclic voltammograms indicating that the observed lack of redox activity of Ag in the 
presence of Ge8 was due to an interaction between the peptide and Ag cations.  
 In an attempt to elucidate the role of specific amino acids of Ge8 on its function, four 
alanine replacement experiments were performed. When either one of the histidines in 
Ge8 were replaced with an alanine, the Ag+/Ag0 redox couple was observed at any 
Ag+:peptide ratio. This suggests that the binding interaction between Ag+ and Ge8 is 
compromised by the loss of a single histidine. Despite the loss of the Ag+/Ge8 
interaction, however, Ag nanoparticle formation was still observed (5 nm ± 1 nm 
diameter; Figure 3.3). When either the methionine or tryptophan residues were replaced 
with alanine, the Ag+/Ag0 redox couple was again only observed at Ag+:peptide ratios 
>3:1. This peptide, however, was unable to mediate the formation of nanoparticles. It 
thus appears that the 3 Ag+:1 Ge8 binding interaction requires the histidine residues, 
while the formation of Ag nanoparticles is dependent upon the presence of both 
methionine and tryptophan but not histidine.  
In addition to systematically replacing select amino acids of Ge8 with alanine, 
two peptides containing more substantial 
changes were investigated. One peptide 
contained both methionine and tryptophan 
(AYSSGAWPMPPF), but was otherwise 
selected to be a largely random sequence 
compared to Ge8. This peptide was found 
to be active toward bulk Ag precipitation as 
observed by visible spectroscopy, but did 
not mediate the formation of stable Ag 
nanoparticles. The presence of methionine 
and tryptophan, although necessary for 
Ge8 function, is not sufficient in general for 
Ag nanoparticle formation by peptides. The 
second peptide contained all of the 
residues of Ge8, but was randomly 
scrambled (MSLPHKPPHWLL) to determine the dependence of amino acid position on 
Figure 3.3. TEM image of particles 
formed using Ge8 containing alanine 
instead of histidine. 
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Ge8 function. Nanoparticle formation was observed with the scrambled Ge8 peptide, 
but with a larger size and size dispersity than particles synthesized with Ge8 (7 nm ± 3 
nm). These data suggest that both the specific amino acids and their primary sequence 
influence Ag+ reduction and Ag nanoparticle growth.  
3.2.2.3. Individual Amino Acids 
The residues in Ge8 that were observed to bind Ag+ (His) and mediate the 
synthesis of Ag nanoparticles (Trp and Met) were investigated individually for function 
toward Ag nanoparticle mineralization. The individual amino acids were incubated with 
10 mM AgNO3 in 100 mM HEPES (pH 7.2) at room temperature and light using the 
same concentration of amino acid present in the peptide sequence. Methionine was the 
only amino acid, of those tested, observed to be capable of Ag nanoparticle synthesis 
as observed by UV-Visible spectroscopy and TEM (Figure 3.4). The particles observed 
were larger and more polydisperse (13 nm ± 5 nm) than those synthesized in the 
presence of Ge8.  These results show that Met is capable of making reducing Ag+ and 
mediating the synthesis of Ag nanoparticles, but the size and size dispersity seems to 
be dependent on primary peptide sequence.  
Figure 3.4. UV-Visible spectrum and TEM image of nanoparticles synthesized from 
a 24 hour incubation of 10 mM AgNO3, 100 mM HEPES and 690 µM methionine in 
room temperature and light.   
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3.2.3. Surface Experiments 
Our interest in using biomolecules to perform surface-bound, spatially resolved 
materials synthesis15 prompted us to investigate the ability of Ge8 to mediate the 
formation of Ag nanoparticles when immobilized onto a surface.  TEM grids were glow 
discharged to provide a negatively charged surface, allowing electrostatic adsorption of 
the peptide onto the surface. Drops (20 µL) of solutions containing various 
concentrations of Ge8 were placed onto grids for two minutes and then the solution was 
wicked away with filter paper, leaving Ge8 adsorbed to the grid. The peptide-coated grid 
was then inverted onto a droplet containing 10 mM AgNO3 and 100 mM HEPES and the 
grid was examined by TEM. Solutions containing 8.7 mM and 4.4 mM Ge8 led to the 
formation of spherical nanoparticles, ca. 20 nm and 10 nm in diameter, respectively, 
following 24 hrs of grid exposure to the Ag+/HEPES droplet. Ge8 transferred to the TEM 
grid from a solution containing 690 mM Ge8, however, yielded high-aspect ratio, curled 
wires, that appear to grow from the points of triangular nanoparticles (Figures 3.5A and 
B). Electron diffraction of the wires revealed six rings in total that could be indexed 
closely to fcc Ag (Figure 3.5C).   
3.2.4. Photochemistry of HEPES 
Figure 3.5. A) and B) TEM images of curled wires formed via immobilized Ge8 
incubated in 10 mM AgNO3 and 100 mM HEPES. C) Diffraction pattern of curled 
wires with d spacings corresponding to 1 (111), 2 (220), 3 (420) labeled.  
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Finally, the photochemistry involved in the synthesis of Ag nanoparticles was 
considered. It has been reported that fluorescent light causes the photodecomposition 
of HEPES in aqueous solution with the concomitant production of H2O2.16 To determine 
if H2O2 might play a role in Ag nanoparticle formation, a solution containing 100 mM 
H2O2 and 10 mM AgNO3 was prepared and kept in the dark. After 24 hrs a black solid 
was observed to form. These results are consistent with those reported by Eychmuller 
et al., who have employed H2O2 as a reducing agent in the synthesis of Ag 
microstructures.17 It is thus plausible that H2O2 produced from the photodecomposition 
of HEPES may be acting as the reducing agent in the production of the Ag 
nanoparticles and nanowires by Ge8. We note, however, that Ge8 must be serving as 
more than a simple nanoparticle capping agent as the production of solid Ag from 
HEPES and light did not occur in the absence of Ge8.  
Peptides isolated via phage display to mediate the formation of inorganic 
nanoparticles are yielding interesting insights into the range of chemistries possible by 
biomolecules and are providing new opportunities to synthesize materials under more 
environmentally benign conditions (e.g. neutral pH, aqueous solutions). Of interest in 
this work was the selectivity of peptides for certain metal precursors and whether 
changes in reaction conditions would lead to changes in peptide function. For instance, 
how does an immobilized peptide behave compared to a freely diffusing peptide? Does 
the buffer system affect materials synthesis? Will a peptide selected to interact with one 
metal precursor accept another precursor?  
The Ge8 peptide was originally selected via phage display to bind to germania. Ge8 
was also discovered to mediate the formation of germania network structures from 
solutions of tetramethoxygermanium in methanol. The work presented here has shown 
that Ge8 is selective and does not by itself mediate the formation of inorganic 
nanoparticles when challenged with a number of other metal and metal oxide 
precursors. This may be contrasted to the behavior of the protein silicatein, which 
tolerates a number of metal precursors.18-20 Surprisingly, however, when Ge8 was 
incubated with Ag+ and HEPES and kept in ambient light for ca. 24 hrs, nanoparticles 
were observed to form. The absence of any one of these components completely 
compromised nanoparticle formation.  
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While the mechanism of Ag nanoparticle formation in the presence of Ge8 remains 
to be elucidated, some information was obtained concerning sequence-function 
relationships and the role of light in the reaction (Figure 3.6). It has been posited by 
others that peptides such as E6 may serve to lower the Ag+ reduction potential. 
However, our studies showed that E6 does not alter the energy required to reduce Ag+. 
Ge8, in contrast, does bind to Ag+ in a 3 Ag+:1 Ge8 ratio, but this appeared to prevent 
rather than promote Ag+ reduction. The key residues involved in Ag+-Ge8 binding were 
determined to be the histidines, although replacing the histidines for alanine revealed 
that Ag+ coordination was not necessary for nanoparticle formation. The most important 
amino acids for Ag nanoparticle formation were methionine and tryptophan. Alanine 
replacement showed an absolute dependence on these residues for Ag particle 
formation. Despite this, methionine and tryptophan were not found to be the exclusive 
requirement for Ag synthesis as another peptide containing these amino acids was not 
Figure 3.6. Summary of the peptides examined in this study and their ability to 
mediate the formation of Ag nanoparticles. 
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able to form stable nanoparticle sols under identical synthesis conditions. The 
arrangement of amino acids in Ge8 proved to be only important to the resulting particle 
size and size dispersity; a scrambled Ge8 peptide produced nanoparticles that were on 
average nearly 2X larger and 3X more polydisperse in diameter. 
The possibility that the relevant photochemical process involved the decomposition 
of HEPES to produce H2O2 was considered and tested by incubating Ag+ and H2O2 in 
the dark. Solid black microparticles were observed to form from this solution, which 
were similar in appearance in the electron microscope to the Ag particles obtained by 
Eychmuller et. al. We propose that the photodecomposition of HEPES, along with its 
inherent reducing power13, should be considered when choosing a buffer system for the 
biological synthesis of metal and metal oxide nanoparticles.  
3.3. Conclusions 
The synthesis of metal and metal oxide nanoparticles in the presence of a peptide 
isolated via phage display has been examined. The peptide of interest in this work, Ge8, 
was originally isolated from a phage library by Sandhage and coworkers8 based upon 
its ability to bind tightly to germania. The most surprising result to emerge from this 
study is that this peptide also mediates the formation of Ag nanoparticles, and product 
formation required the presence of the peptide, HEPES, and light. In addition, it was 
determined that H2O2 produced via the photoinduced decomposition of HEPES is likely 
a key reactant in Ag+ reduction. In contrast to a prior hypothesis suggesting that the role 
of Ag-forming peptides is to lower the energy of Ag+ reduction, the peptides studied 
here (e.g., Ge8, E6) either did not lower the formal potential of the Ag+/Ag0 redox couple 
or made the redox couple completely inaccessible within the potential window explored 
(0.8 V to -0.4 V vs. Ag+/AgCl). Finally, we have observed a dramatic change in particle 
growth upon immobilizing Ge8 on a solid support. The Ge8 peptide, which formed 
exclusively spherical nanoparticles in solution, produced Ag nanowires when adsorbed 
onto a TEM sample grid. The wires appeared to grow from the points of triangular 
nanoparticles. These studies illustrate that Ag nanoparticle formation reactions 
mediated by peptides do not require a lowering of Ag+ reduction potentials and that 
decomposition reactions involving buffers such as HEPES can produce active 
byproducts that influence the production of inorganic nanoparticles. 
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The peptide Ge8 was shown to be highly selective towards mediating materials 
synthesis; the formation of metal nanoparticles was only observed in solutions 
containing Ge8, AgNO3 and HEPES in room light and temperature. When Ge8 was 
presented with other metal precursors under the same reaction conditions, 
nanoparticles were not observed. The Ag nanoparticles that are a product of this 
reaction are electron dense, thus readily imaged via electron microscopy. Additionally, 
this peptide also maintained function when immobilized. The aforementioned 
characteristics suggest that Ge8 could be attached to another molecule, for example a 
protein moiety, and mediate the formation of a Ag nanoparticle that would then be 
attached to the protein. The nanoparticle could then serve as a unique identifier for the 
protein moiety. A unique nanoparticle attached to a protein would provide a means of 
differentiating one protein from another in solution, or in a cell, where proteins are 
typically unidentifiable from one another via electron microscopy. 
Given the advent of cryo-electron tomography, where whole cells can be frozen 
(vitrified) and imaged, the ability to label one intracellular protein in a specific and 
unique manner would allow for a better understanding of that intracellular protein’s 
location and possible interactions. If multiple proteins in a cell were equipped with RNA 
or protein tags with similar selectivity and immobilized function as Ge8, nearly every 
protein in the cell could be uniquely identified, and the intracellular protein-protein 
interactions studied. The concept of unique and specific intracellular protein labels 
(genetically encodable tags) will be discussed in detail the following chapter. 
 
3.4 . Experimental 
3.4.1 Reagents 
All reagents were used as received from the manufacturer. All solutions were made 
using high purity water (18.2 MΩ, Millipore) and adjusted to the appropriate pH using 
NaOH, HCl or HNO3. All peptides were purchased from Genscript. HEPES (4-(2-
hydroxyethyl)-1-piperazineethanesulfonic acid) and AgNO3 (Certified ACS) were 
purchased from Fisher (BioReagent, 1 M, pH 7.3).  Individual amino acids were 
purchased from Sigma.  
3.4.2 Materials and Methods 
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Nanoparticle Synthesis 
Peptide Ge8 (SLKMPHWPHLLP), the scrambled Ge8 (MSLPHKPPHWLL), random 
(AYSSGAWPMPPF) or mutant peptides (SLKAPHWPHLLP, SLKMPAWPALLP, 
SLKMPHAPHLLP) (690 µM) were combined with 10 µM-10 mM AgNO3 in the presence 
of 100 µM-1 mM HEPES at room temperature, in light, in a sealed eppendorf tube. Trp 
(250 µM- 1 mM), Met (250 µM-1 mM) or His (500 µM-2.7 mM) were incubated as 
described above.  
Transmission Electron Microscopy 
Electron Microscopy was performed using a Phillips CM100 with and 
accelerating voltage of 100 kV. The images were obtained on an AMT CCD (2k x 2k).  
Typically a 20 µL drop of the nanoparticle solution was placed onto a glow discharged 
TEM grid (300 mesh carbon coated copper, EM science) for 30 seconds and the 
solution was wicked away. Peptide immobilization was achieved by placing a 20 µL 
drop of 690 µM Ge8 onto a glow-discharged grid for 2 minutes and the solution was 
wicked away. The grid was then inverted onto a droplet containing the appropriate 
concentration of AgNO3 and HEPES. The inverted reactions were kept in a humid 
environment for 24h to avoid evaporation.  The grid was then removed from the droplet 
and the solution wicked away.  
 Electron Diffraction  
Diffraction data was collected on a FEI F20 transmission electron microscope 
with a 200 kV accelerating voltage equipped with a 4k x 4k Gatan CCD (15 µm pixel 
size). The camera length was determined by obtaining a diffraction pattern from the Cu 
grid bar. The grid bar diffraction was indexed to elemental copper, allowing the 
assignment of a camera constant to the experimental data, which were collected with 
identical objective and C2 lens settings. 
 UV-Visible spectroscopy 
UV-visible spectra were obtained using either a Genesys 10UV Scanning 
spectrophoteter (Thermo) or a FLUOstar Omega plate reader (BMG Labtech).  
 Electrochemistry 
 Electrochemical measurements were performed using a 3 mm glassy carbon 
electrode with 100 mM KNO3 as supporting electrolyte. A Ag/AgCl electrode was used 
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as a reference, while a Pt wire was used as the counter electrode. All cyclic 
voltammograms were performed using a BASi potentiostat. 
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4. Chapter 4: Genetically Clonable Tags 
4.1.  Introduction 
Current imaging technology and analytical techniques provide the means to identify 
and characterize biological structures over a wide range of length scales from whole 
tissues and cells to the atomic-level structure of individual proteins. However, there is a 
size regime ranging from a few nanometers to ~100 nm that cannot be readily accessed 
using available techniques.1 So, while databases of sequence and structural information 
exist for RNA, DNA, peptides and proteins, the intracellular interactions of these 
materials remain mostly unclear. The ability to visualize and identify intracellular 
molecules would provide a clearer picture of in vivo bio-molecular interactions.  A 
precise picture of intracellular interactions would in turn provide a better understanding 
of the connection between protein-protein interactions and disease. 
Electron tomography is a microscopy technique that enables the visualization of whole 
cells by reconstructing multiple images taken at a variety of angles into one 3-D image. 
The sample is vitrified (frozen) and imaged in a near native state, allowing for a true 
image of the intracellular medium. Individual proteins can be visualized using electron 
Figure 4.1 Genetically encodable tag scheme. Intracellular proteins are engineered 
to be a chimera of a peptide that is capable of mediating the formation of metal 
nanoparticles. Metal precursors are introduced, and unique nanomaterials are 
formed at each chimera, identifying one from the other via shape, size or 
composition. The nanomaterials formed can be identified via electron tomography in 
combination with elemental analysis techniques.  
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tomography, however, proteins can rarely be uniquely identified due to their low 
contrast.2 Proteins visualized via electron tomography are typically identified by 
performing a series of positive and negative control (over-expression, gene mutations) 
tomograms. There is currently no method of directly identifying protein in an electron 
tomogram. A genetically clonable, electron dense tag for proteins—similar in function to 
green fluorescent protein tags now commonly used for fluorescence microscopy— 
would be an innovative and enabling for cell biology.    
Intracellular protein tagging could be 
accomplished by genetically modifying a 
native protein so that it is expressed as a 
chimera containing a peptide capable of 
mediating the formation of nanoparticles 
(a “materials enzyme”; Figure 4.1). Unique 
(size, morphology, crystallinity, 
composition) nanomaterials synthesized 
on or near a protein could serve as an 
identifier for that specific protein. Metal or 
metal oxide nanoparticles synthesized in 
vivo could then be identified using cyro-
electron tomography (CET) in combination 
with an elemental analysis technique such 
as EELS (electron energy loss 
spectroscopy) or EDS (energy dispersive X-ray spectroscopy). Likewise, RNA 
sequences capable of mediating the formation of metal or metal oxide nanoparticles 
(materials ribozymes) could be concatenated to cellular RNA molecules of interest.  
We have been developing materials enzymes and ribozymes for use as genetically 
clonable tags for electron tomography. Several steps were involved in determining 
viable candidates as genetically clonable tags (Figure 4.2).  The first step, the 
identification of possible RNA and protein sequences capable of synthesizing unique 
nanomaterials, was described in chapters two and three.3, 4 Once the sequences of 
interest had been identified it was necessary to determine if an RNA or protein tag could 
Figure 4.2 Flowchart of the steps 
necessary to identify a viable genetically 
clonable tag.  
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be engineered and expressed as a chimera of a native protein without compromising 
the function of either entity. Finally, in vivo activity would ultimately need to be confirmed 
by obtaining a tomogram of nanoparticles synthesized inside of a cell. 
The following describes the engineering of three protein chimeras and the studies 
performed to determine the viability of each chimera to function as an in vivo tag.  Gene 
engineering and protein expression and purification conditions were optimized for each 
chimera. The individual fusion proteins were examined for their ability to synthesize 
nanomaterials via UV-Visible spectroscopy and TEM.   
4.2. Results and Discussion 
4.2.1. Ge8 chimera 
Peptide Ge8 (chapter 3) was shown to be 
selective toward Ag nanoparticle formation in 
vitro.4 Ag nanoparticle formation was only 
observed under a set of necessary conditions 
(HEPES, light, Ag+, and peptide).  The peptide 
was made into a chimera of bacterioferritin (Bfr) 
and tested for its ability to maintain function when 
concatenated to a larger protein. A plasmid was 
designed to express (Ge8)3 as part of the ferritin 
monomer. Ideally, 24 ferritin monomers would 
assemble into a Bfr cage, with 24 Ge8 trimers 
coating the outside of the cage. This fusion protein 
was successfully expressed and purified as 
confirmed by SDS-PAGE (Figure 4.3). Post 
expression cell pellets of (Ge8)3Bfr surprisingly contained large (visible by eye) black 
precipitates, not typically observed in a normal cell pellet, nor a cell pellet of Bfr only. 
The (Ge8)3Bfr cell pellet was resuspended in buffer and the black precipitate proved to 
be highly magnet responsive. The identity of the magnetic material and the conditions 
under which it is synthesized are currently being examined, although its color and 
response to a magnetic field are highly suggestive of magnetite (Fe3O4).  
Figure 4.3 5-10% stacked SDS-
PAGE. Lane B contains the 
ladder, Lane C is empty and 
Lane D (red box) contains 
purified Ge83Bfr.  
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The (Ge8)3Bfr protein was additionally examined for its ability to synthesize Ag 
nanoparticles in vitro. The chimera was incubated with 10 mM AgNO3, 100 mM HEPES 
buffer (pH 7.2) in room light and temperature, yielding a pale orange color in 
approximately two hours. UV-Visible spectroscopy showed a broad plasmon resonance 
band centered around 520 nm, indicating polydisperse Ag nanoparticle formation 
(Figure 4.4A). Similar results were obtained with the Ge8 monomer, however (Ge8)3Bfr 
yielded particle formation 10X faster at a concentration 200X lower than the Ge8 
monomer under the same conditions. Additionally, TEM showed 4.3 nm ± 0.9 nm (50+ 
particles measured) nanoparticle formation in the presence of the Ge8 monomer,4 while 
larger particles (6 nm ± 4 nm)  were observed to form in the presense of (Ge8)3Bfr 
(Figure 4.5A). Experiments in which negative stain (NanoVan) was applied to the TEM 
grid following sample deposition show protein associated with the observed 
nanoparticles (Figure 4.5B). This protein is approximately 10 nm in diameter and is 
likely the Bfr protein. The 10 nm diameter spherical protein moieties indicate that Bfr 
self-assembly was not compromised. 
The change in reactivity, compared to the Ge8 monomer, may have been due to the 
presence of Bfr.  To examine the role of native Bfr in Ag nanoparticle formation, the 
(Ge8)3Bfr plasmid was digested to remove the Ge8 trimer gene, leaving only the Bfr 
Figure 4.4  UV-Visible spectrum of 10 mM AgNO3 and 100 
mM HEPES incubated with A) 1 µM (Ge8)3Bfr B) 1 µM Bfr for 
2 hours at ambient light and temperature.   
 
A 
B 
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codons. Bfr was successfully expressed and isolated (Figure 4.6). Notably, large black, 
magnet responsive material was not observed in the cell pellet, as was observed in the 
(Ge8)3Bfr pellet post-expression, indicating that the the Ge8 
trimer may be responsible for the production of the observed 
magnetic material. Incubations were then performed with Bfr in 
the same manner previously described for (Ge8)3Bfr. The 
solutions were analyzed via UV-Visible spectroscopy (Figure 
4.4B).  Bacterioferritin appeared to be capable of reducing Ag+, 
however, Ag nanoparticle formation was not evident. 
In summary, peptide Ge8 was successfully synthesized as 
a chimera of Bfr. Additionally, Ge8 maintains activity for Ag 
nanoparticle formation even though it is tethered to a large 
(480 kDa) self-assembling protein. The negative stained TEM 
image shows that Bfr was also able to maintain function, 
assembling into a cage, as a chimera of Ge8. The 
aforementioned results with Ge83Bfr satisfy the first three 
criteria for a genetically clonable tag.  
4.2.2. Fe protein chimeras 
Native iron-binding proteins have been identified in plants, 
humans, animals and bacteria.7 The primary function of these 
proteins is to store and often regulate iron in vivo. This section focuses on 
Figure 4.6 5-10% 
stacked SDS-PAGE. 
Lane A contains the 
protein marker (kDa), 
lane B contains a 
purified aliquot of Bfr. 
Figure 4.5 A) Unstained and B) negative stained TEM images 
of Ag nanoparticles formed in the presence of Ge83Bfr.  
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bacterioferritin (Bfr) and a protein associated with magnetotactic bacteria (Mms)8 as 
possible genetically encodable tags.  
Bacterioferritin (Bfr) is a thoroughly studied protein found in bacterial cells. It is 
comprised of 24 polypeptide subunits. Two monomer subunits (Figure 4.7A) side-by-
side create a binuclear ferroxidase site where toxic Fe2+ ions are oxidized to non-toxic 
Fe3+ (as ferric-oxyhydroxide phosphate) and sequestered in the 8 nm diameter Bfr 
“cage” (Figure 4.7B). The 8 nm cage accommodates 4500 Fe3+ atoms. The residues 
required for the full assembly of Bfr are known and can be altered to prevent full cage 
assembly, resulting in only dimer formation.9,10The ferroxidase site remains active in the 
assembly deficient dimers.  
Magnetotactic bacteria (Magnetospirrilum) have the ability to synthesize Fe3O4 in 
vivo. Many proteins in this organism have been identified to play some role in mediating 
the synthesis of magnetite. The Mms family of proteins has been observed to bind 
tightly to magnetite synthesized in vivo.11 It is not clear what role Mms proteins play in 
the iron chemistry.  
These two proteins (Bfr and Mms) that interact with Fe in vivo have been well 
studied.7, 12 While it seems that neither of these proteins could make and bind 
nanoparticles on their own, combining them may provide the necessary circumstances 
Figure 4.7 Pymol images of A) ferritin dimer, with red arrow indicating the ferroxidase 
site and B) the bacterioferritin “cage”. 
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for in vivo Fe or Fe oxide nanoparticle formation. Ideally, the assembly deficient ferritin 
monomers would create the ferroxidase site, where Fe oxidation would occur. The Mms 
protein could then bind any iron nanoparticles synthesized, since the ferritin will not be 
fully assembled and therefore unable to sequester Fe alone.  
The unique interactions of each of these proteins with iron led to further experiments 
with genetically encodable tags. Two assembly deficient ferritin monomers were joined 
with a Gly16 bridge. The glycine bridge was designed to provide enough freedom for the 
ferritin monomers to interact and potentially form the ferroxidase site. Linking the two-
ferritin monomers together and maintaining function was essential to ensure localization 
of a tag in later experiments. The active site (C-terminal acidic triplets of amino acids)11 
of two Mms6 (6 kDa) proteins was then added to the C-terminus of the ferritin dimer to 
create a protein that could theoretically both oxidize and bind iron.  We called this 
protein FLFMMS6 (Figure 4.8).  
4.2.2.1. FLFMMS6 and Truncations FLF and MMS6 
The FLFMMS6 protein was successfully expressed and 
purified from BL21 DE3 pLysS chemically competent E. 
coli (Figure 4.9). These cells were used as ordered; 
mutations to remove native ferritin and DPS (DNA 
protection sequence from starved cells, another native 
iron binding protein) production were not performed. After 
the protein was expressed, the cells were pelleted in 
preparation for lysis. Surprisingly, the cell pellet was pink 
(Figure 4.10B).  The pink color, compared to the 
white/beige color (Figure 4.10A) of a typical cell pellet, 
was an indication of in vivo iron activity. Interestingly, the 
protein maintained this red color throughout various purification steps (lysis, affinity 
column, Q-column, and desalting on Amicon filters), further indicating in vivo activity for 
iron oxide formation. The cell growth and expression media was not supplemented with 
Figure 4.8 Cartoon of FLFMMS6 insert with restriction sites and affinity tags labeled.  
Figure 4.9 8-10% stacked 
SDS-PAGE. Lane B contains 
the protein. Lanes C, D and 
E contain purified FLFMMS6 
(~ 50 kDa, red box) aliquots.  
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Fe, so the protein must have a high affinity for trace 
Fe in the growth medium compared to native iron 
proteins, which are only expressed at high (mM) Fe 
concentrations.   
Upon purification, the “as is” protein was 
concentrated, washed and dialyzed with water to 
remove excess elution buffer. Transmission 
electron microscopy revealed spherical 
nanoparticles 6.8 nm ± 4.4 nm (50 particles, Figure 4.11).  It appeared as if the protein 
not only mediated the formation of nanoparticles in vivo but also remained tightly bound 
to them, since they were present after all of the purification steps. Electron diffraction 
(Figure 4.12) patterns obtained of the observed nanoparticles suggest that the material 
is α-FeOOH (Table 4.1).  
We were also interested in determining whether or not the full FLFMMS6 construct 
was required for particle formation. The original plasmid for FLFMMS6 was designed to 
include unique restriction sites around each entity (FLF or MMS6) so that plasmid 
digestion could be easily accomplished (Figure 4.8). The plasmid was successfully 
Figure 4.10 Photograph of 
cell pellets A) without and B) 
with FLFMMS6.  
A B 
Figure 4.11 TEM image and electron diffraction pattern of 
nanoparticles associated with FLFMMS6. The observed d-spacings 
matched well (5% error) with  α-FeOOH.  
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digested to create two new constructs, FLF and (MMS6)2.13 Each of these proteins were 
successfully expressed and purified, as confirmed by SDS-PAGE (Figures 4.12).  
The FLF truncation was observed to create pink pellets post-expression, and 
maintained a red color throughout purification, similar to FLFMMS6. Transmission 
electron microscopy (TEM) showed spherical nanoparticles, however these particles 
were of a different size than those observed from FLFMMS6.  The nanoparticles 
observed from FLF were 4 nm ± 1 nm (50 particles, Figure 4.13A). The MMS6 dimer did 
not have any observable color upon pelleting or during purification. However, 8 nm ± 2 
nm nanoparticles were observed by TEM (50 particles, Figure 4.13B).   
Electron diffraction was used to determine the identity of the material synthesized by 
each truncate. Surprisingly, the diffraction patterns for the materials observed from FLF 
 
Table 4.1 Observed and known d-spacings for each of the 
iron species associated with FLFMMS6, FLF and MMS6. 
The assigned iron species (within 5 % of the known value) 
for the material associated with each protein is listed below 
with known d. The known d values highlighted in red indicate 
the most intense reflection for that phase of iron. The 
corresponding plane for each d-spacing is also listed.  
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and MMS6 matched well with the known d-spacings for 
γ-Fe2O3 (maghemite, within 5% error of known values, 
Figure 4.14). The known d-spacings for γ-Fe2O3 are 
nearly identical to the known d-spacings for Fe3O4 
(magnetite) therefore the materials observed are 
tentatively assigned as magnetite/maghemite.   
It should be noted that the observed d-spacings for 
the materials associated with FLFMMS6, FLF and 
MMS6 were also compared to several different phases 
of iron (β and γ-FeOOH, α-Fe2O3, Fe3O4, FeO) and 
NaCl in addition to the assigned phases of iron. Table 
4.1 lists the known d-spacings for NaCl. While some of 
the observed values were within 5% of the known value 
for NaCl we are hesitant to attribute the observed 
diffraction patterns to NaCl because multiple steps were 
taken to eliminate salt from the sample. Following affinity column purification the elution 
fractions were concentrated and washed (H2O) on MWCO filters. Dialysis (4000:1 
H20:protein (v/v)) was then employed, for 24 hours, to further remove unwanted salts. 
Furthermore, the TEM samples were prepared so that the solution was not allowed to 
evaporate on the grid. A 20 µL drop of concentrated, dialyzed protein was placed on a 
glow discharged grid for two minutes allowing the protein to adsorb to the grid surface. 
The solution was then wicked away with filter paper, ideally leaving behind only protein 
and the material associated with it.  
Figure 4.12 Left: 8-10% 
stacked SDS-PAGE. Lane A 
contains the protein marker, 
labeled in kDa. Lanes B,C, D 
and E contain purified FLF (~ 
40 kDa) aliquots. Right: 10-
20% stacked SDS-PAGE. 
Lane A contains an aliquot of 
purified MMS6 (~ 5 kDa). 
The protein marker is in lane 
B, labeled in kDa.  
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4.2.3. Preparation for electron tomography 
Electron tomographic imagine of E. Coli. can be difficult due to the thickness of the 
cells. In an effort to conclusively determine whether or not nanoparticles were being 
synthesized in vivo the plasmids that code for FLFMMS6, FLF and MMS6 were 
individually transformed into “skinny” E. coli (modified BW25113). The skinny E. coli are 
thinner than native E. coli and provide a better system for tomographic imaging. The 
Figure 4.14 Electron diffraction patterns obtained from nanoparticles 
found in A) MMS6 and B) FLF. The blue circle indicates a spot correlated 
to 5.90Å (110), the most intense reflection for γ-Fe2O3. 
Figure 4.13 TEM images of materials observed in purified protein samples 
of  A) MMS6 and B) FLF.  
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skinny cells, however, were not meant for protein 
expression, and so phage infection and lysogenization 
were employed to create a protein expression system in 
these thin cells. The skinny E. coli contained no antibiotic 
resistance on their own, however the plasmids for 
FLFMMS6, FLF and MMS6 are resistant to ampicillin. 
Therefore, the growth of these cells in media containing 
ampicillin indicated that the plasmids were successfully 
transformed into the skinny cells. Following 
transformation, lysongenication was employed to infect the 
cells with λDE3 phage containing the necessesary T7 
RNA polymerase (for expression) without killing the 
bacteria.  
Expression conditions for FLFMMS6 in skinny cells 
were identified, and the protein purified (Figure 4.15) from 
these cells was observed to have a red color similar to 
that observed in previous experiments.  The plasmids that 
code for the two truncated proteins have also been 
transformed into skinny E. coli and successfully expressed and purified. The successful 
expression of these proteins in the skinny E. coli indicates that the lysogenication 
procedure worked, otherwise protein expression would not have occurred. Our 
observations suggest that each of these proteins is capable of mediating the formation 
of iron oxide nanoparticles in vivo and of making different types and sizes of materials.  
We are thus poised to begin studies of these cells by electron tomography.  
4.3. Conclusions 
The first several criteria in the process of identifying candidates for genetically 
clonable tags have been statisfied. We have identified biomolecules capable of 
mediating the synthesis of materials and engineered chimeras without compromising 
function of either portion of the chimera. The function of the chimeras was confirmed via 
in vitro studies (Ge83Bfr) and in vivo studies (iron chimeras). In addition, skinny E. coli 
have been prepared for electron tomography. The E. coli were engineered to contain 
Figure 4.15 5-10% 
stacked SDS-
PAGE. Lanes A 
and B contain 
FLFMMS6 purified 
from skinny E. Coli. 
Lane B shows the 
protein marker, 
labeled in kDa.  
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the plasmids for either FLFMMS6, FLF or MMS6, and made into lysogens so that 
protein expression could be achieved. 
The Ge8 trimer shows some potential to be a genetically encodable tag. The peptide 
maintains the ability to mediate the formation of Ag nanoparticles when attached to a 
larger protein (Bfr). Increasing the local concentration of Ge8 (compared to monomer 
studies) decreases both the required reaction time and the concentration of AgNO3 
required for Ag nanoparticle formation. Decreasing the Ag+ concentration may decrease 
the antimicrobial activity reported,15 making it a viable metal salt precursor for a living 
cell. However, this reaction requires the presence of a reducing agent (HEPES). The 
large black magnetic material observed in the cell pellet may be synthesized in vivo due 
to the presence of the Ge8 trimer. The trimer may be another genetically encodable tag 
capable of mediating the formation of an iron oxide from trace iron. The Ge83Bfr 
chimera allowed us to show that the peptide maintained function while attached to a 
large self-assembling protein, without inhibiting the assembly of Bfr. These experiments 
provided a proof-of-concept that chimeras could serve as in vivo bio-markers.  
The iron chimeras also show potential to function as genetically encodable tags. 
These proteins are readily expressed under normal expression conditions (37°C, 2-4h), 
and have a high affinity for trace iron available in the culture media, synthesizing 
nanoparticles in vivo.  The iron oxide nanoparticles are high contrast and so are 
potentially able to be identified inside of a cell during a vitreous experiment. 
Furthermore, we have identified the materials synthesized in the presence of 
FLFMMS6, FLF and MMS6, so they may be used in combination with tags for other 
types of materials (Ge8-Ag). The materials could be differentiated using EM in 
combination with EDS, for example.   
Finally, skinny E. coli have been engineered to express these materials enzymes, a 
key step in imaging the nanomaterials synthesized by FLFMMS6, FLF or MMS6 
intracellularly. The aforementioned experiments demonstrate the first attempts at 
creating viable biomarkers (genetically clonable tags) for tomographic imaging of 
uniquely identifiable proteins.   
 
4.4. Experimental 
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4.4.1. Reagents 
All plasmids were synthesized by BioBasic. HEPES, and AgNO3 solutions were filter 
sterilized prior to use (0.22 µm, Millipore). All water was 18.2 MΩ MilliQ. Liquid Amp and 
LB Agar Amp were purchased from Fermentas and used as directed. Chloramphenicol 
and Isopropyl β-D-1-thiogalactopyranoside (IPTG), NaCl, CaCl2 were purchased from 
Fisher and used as received. Bacto-tryptone and Bacto-Yeast were purchased from BD. 
Restriction (NsiI and SpeI) and ligation (T4 ligase) enzymes were purchased from 
invitrogen. 
4.4.2.    Materials and Methods 
 Plasmid engineering 
 The desired inserts were placed in the cloning and sequencing region of a pet15b 
vector. Typically, the insert was placed between XhoI and NdeIII, allowing for the native 
6X His tag to be amplified as part of the desired protein. This placement also allowed for 
simple IPTG induction in later experiments. The C-terminus of the insert was followed 
by the codons for a Strep II tag for later purification. The TEV sequence was placed in 
between the protein codons and the Strep II codons so that it could easily be removed 
with TEV protease if necessary. Restriction sites (SpeI or NsiI) were placed around 
either the FLF, (MMS6)2, (Ge8)3 or Bfr portions of the insert so that the chimeras could 
be truncated and used in control experiments.  
Plasmid amplification and quantitation 
 The plasmids were amplified using a Maxi-prep (Invitrogen) kit exactly as directed. 
Quantitation was performed by measuring the OD260 of the purified DNA. 
FLFMMS6 digestion 
Typically 5 µg of plasmid DNA was incubated in 1X REact buffer (Invitrogen), with 10 
U of the restriction enzyme (SpeI or NsiI, Invitrogen) for 2 h at 37°C. The digested 
plasmid was not purified. 
Plasmid ligation 
25 µL of the digested plasmid was combined with 2000 units T4 ligase (NEB) and 1X 
T4 DNA ligase reaction buffer (NEB) for 12 h at 16°C. The reaction was then held at 
65°C for 10 minutes to deactivate the enzyme. The reaction was then held at 4°C until 
transformation was performed. 
58 
Transformation, Protein Expression and Induction 
 Plasmid DNA was transformed into chemically competent BL21 Codon Plus E. coli. 
following procedures outlined by Stratagene (protocol 230240-12). Using the pet15b 
vector in this particular cell line allowed for double resistance, so that we could confirm 
the presence of our plasmid unequivocally. Inductions were done for either 2h or 4h 
using 1 mM IPTG.  
Protein purification: Ferritin Dimer Proteins 
 Following induction, liquid cultures were pelleted at 8,000 x g for 5 min and placed 
at -20 °C overnight. The cell pellets were taken up in 1X PBS (pH 7.2) and lysed by 
repeated (4X) freeze (l-N2)/ thaw (37 °C) or via chemical lysis (Thermo B-PER lysis kit). 
The cell debris was removed via centrifugation (16.1 x g, 5 min). The lysate (FLFMMS6, 
FLF and (MMS6)2) was then purified using a Strep II Resin and published procedure 
was followed exactly, however EDTA was not included in the buffers.16 FLFMMS6 and 
FLF required additional purification on a Q-column. Protein purity was verified via SDS-
PAGE where aliquots of pre and post induction, lysate, column flow through, washes 
and elutions were examined on homemade or pre-poured stacking gels (Bio-Rad). The 
proteins were concentrated on the appropriate molecular weight cut-off filter (Amicon) 
and dialyzed into water. 
Protein purification: (Ge8)3Bfr  
 Following induction, liquid cultures were pelleted at 8,000 x g for 5 min and placed 
at -20 °C overnight. The cell pellets were taken up in 1X PBS (pH 7.2) and lysed by 
repeated (4X) freeze (l-N2)/ thaw (37 °C) or via chemical lysis (Thermo B-PER lysis kit). 
The cell debris was removed via centrifugation (16.1 x g, 5 min). The protein was then 
removed from the lysate using the Qiagen Ni-NTA Fast Start kit. Protein purity was 
verified via SDS-PAGE where aliquots of pre and post induction, lysate, column flow 
through, washes and elutions were examined on homemade or pre-poured stacking 
gels (Bio-Rad). The purified protein was then concentrated on a molecular weight cut-off 
filter (Amicon) and dialyzed into 100 mM HEPES buffer (pH 7.2). 
Protein Quantitation 
 Bradford reagent (5X, Bio-rad) was diluted to 1X with MilliQ 18 MΩ H2O. 1 mL of 1X 
Bradford reagent was mixed with 100 µL of BSA (Bio-rad) standard (0.1 mg/mL – 1 
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mg/mL) to create a standard curve. Typically 3 different volumes of unknown protein 
concentration were diluted to 100 µL with 18 MΩ MilliQ H2O and then mixed with 1 mL 
1X Bradford. The OD595 values for the unknown protein concentration were converted to 
mg/mL using the equation for the line obtained from the standard curve.  
Expression in Skinny E. Coli.  
 A 10 mL overnight culture of skinny E. Coli. (BW25113) was diluted to 200 mL in  
2X LB (4g bacto-tryptone, 2 g bacto-yeast, 2.8 g NaCl) and grown to an OD600 of 0.1. 
The cells were pelleted at 8,000 x g and 4°C for 5 min. The cell pellet was then 
resuspended in 50 mL 10 mM cold NaCl and incubated on ice for 10 min. The cells 
were again pelleted as previously described, and then resuspended in 50 mL 75 mM 
cold CaCl2 and left on ice for 35 min. The cells were again pelleted and resuspended in 
3 mL 75 mM cold CaCl2. Cold 100% glycerol (0.5 mL) was added to the 3 mL volume, 
the solution remained on ice for 1 hour. The cells were then aliquoted and stored at -
80°C. Plasmid DNA was transformed into the chemically competent skinny e. coli. 
following previously described protocols.  These cells were then infected with phage 
using a λDE3 Lysogenication kit (Novagen) to incorporate the codons for T7 
polymerase into the genomic DNA of the skinny cells. Following lysogenization the cells 
were grown in LB-Amp and induced and purified as previously described. 
UV-Visible Spectroscopy 
UV-visible spectra were obtained using either a FLUOstar Omega plate reader 
(BMG Labtech).  
Transmission Electron Micrscopy 
Electron Microscopy was performed using a Phillips CM100 with and accelerating 
voltage of 100 kV. The images were obtained on an AMT CCD (2k x 2k).  Typically a 20 
µL drop of the nanoparticle solution was placed onto a glow discharged TEM grid (300 
mesh carbon coated copper, EM science) for 30 seconds and the solution was wicked 
away. Peptide immobilization was achieved by placing a 20 µL drop of 690 µM Ge8 
onto a glow-discharged grid for 2 minutes and the solution was wicked away. The grid 
was then inverted onto a droplet containing the appropriate concentration of AgNO3 and 
HEPES. The inverted reactions were kept in a humid environment for 24h to avoid 
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evaporation.  The grid was then removed from the droplet and the solution wicked 
away. Negative staining was performed using NanoVan (Nanoprobes).  
Electron Diffraction 
Electron diffraction was obtained using an AMT CCD (2k x 2k) on a Phillips CM100 with 
an accelerating voltage of 100 kV. The nominal reported camera length was 175 mm. 
Experimental d-spacings were compared to known values for Ag or phases of Fe3O4, 
Fe2O3, FeOOH, FeO and NaCl depending on the precursor material used.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
61 
4.5. References 
1. Ball, P., Nature 2003, 421, 422-422. 
2. Jensen, G. J.; Briegel, A., Current Opinion in Structural Biology 2007, 17, 260-
267. 
3. Carter, C.; Dolska, M.; Owczarek, A.; Ackerson, C.; Eaton, B.; Feldheim, D., J 
Mater Chem 2009, 19 (44), 8320. 
4. Carter, C. J.; Ackerson, C. J.; Feldheim, D. L., ACS Nano 2010, 4, 3883-3888. 
5. Butts, C. A.; Swift, J.; Kang, S.; Constanzo, L.; Christianson, D. W.; Saven, J. G.; 
Dmochowski, I., Biochemistry 2008, 47, 12729-12739. 
6. Uchida, M.; Klem, M.; Allen, M.; Suci, P.; Flenniken, M.; Gillitzer, E.; Varpness, 
Z.; Liepold, L.; Young, M.; Douglas, T., Adv. Mater. 2007, 19, 1025-1042. 
7. Andrews, S. C.; Arosio, P.; Bottke, W.; Briat, J.; von Darl, M.; Harrison, P. M.; 
Laulhere, J.; Levi, S.; Lobreaux, S.; Yewdall, S., J. Inorg. Biochem. 1992, 47, 
161-174. 
8. Arakaki, A.; Webb, J.; Matsunaga, T., Journal of Biological Chemistry 2003, 278 
(10), 8745-8750. 
9. Malone, S.; Lewin, A.; Kiic, M.; Svistunenko, D.; Cooper, S.; Wilson, M.; Le Brun, 
N.; Spiro, S.; Moore, G., JACS 2003, 126 (2), 496-504. 
10. Wong, S.; Tom-Yew, S.; Lewin, A.; Le Brun, N.; Moore, G.; Murphy, M.; Mauk, 
A., Journal of Biological Chemistry 2009, 284 (28), 18873-18881. 
11. Amemiya, Y.; Arakaki, A.; Staniland, S. S.; Tanaka, T., Biomaterials 2007, 28. 
12. Harrison, P. M.; Arosio, P., Biochim. Biophys. Acta 1996,  (275), 161-203. 
13. Gifford, J., 2010. 
14. Briegel, A., 2010. 
15. Asharani, P.; Low Kah Mun, G.; Hande, M.; Valiyaveettil, S., ACS Nano 2008, 3 
(2), 279-290. 
16. Schmidt, T.; Skerra, A., Nature 2007, 6 (2), 1528-1535. 
 
 
 
 
62 
5. Bibliography 
 
The Fiber Optic Association. http:/www.thefoa.org/tech/fibr-mfg.htm (accessed 
01/17/2010). 
A Guide to Anti-Reflective Coatings. http://www.xerocoat.com/Anti-Reflective-
Coatings.aspx (accessed 01/17/2010). 
Aizenberg, J., Muller, D.A., Grazul, J.L., Hamann, D.R., Science 2003, 299, 1205-1208. 
Matsunaga, T.; Arakaki, A.,  J. Biol. Chem. 2003; Vol. 278, pp 8745-8750. 
Vukusic, P., Sambles, J. R., Nature 2003, 424, 852-855. 
Waldrop, M. M. Scientific American Magazine November 2007, 2007, p 4. 
Milius, S.,  ScienceNews January 10, 2010. 
Smith, D.; Charlton, J.,  RNA, 1999; Vol. 5, pp 1326-1332. 
Sewell, S. L.; Wright, D. W., Chem. Mater., 2006; Vol. 18, pp 3108-3113. 
Joyce, G. F., Angewandte Chemie 2007, 46, 6420-6436. 
Gugliotti, L. A.; Eaton, B. E.; Feldheim, D. L., Science 2004, 304, 850-852. 
Carter, C.; Dolska, M.; Owczarek, A.; Ackerson, C.; Eaton, B.; Feldheim, D., J Mater 
Chem 2009, 19 (44), 8320. 
Dickerson, M. B.; Naik, R. R.; Stone, M. O.; Cai, Y.; Sandhage, K. H., Chem. Comm. 
2004, 1776-1777. 
Ahmad, G.; Dickerson, M. B.; Church, B. C.; Cai, Y.; Jones, S. E.; Naik, R. R.; King, J. 
S.; Summer, C. J.; Kroger, N.; Sandhage, K. H., Adv. Mats. 2006, 18, 1759-1763. 
Naik, R. R.; Jones, S. E.; Murray, C. J.; McAuliffe, J. C.; Vaia, R. A.; Stone, M. O., Adv. 
Func. Mats. 2004, 14 (1), 25-30. 
Smith, G. P., Petrenko, V.A., Chem. Rev. 1997, 97 (2), 391-410. 
Lee, S.; Belcher, A., Adv. Mats. 2003, 15 (9), 689-692. 
Yoo, P.; Zacharia, N.; Doh, J.; Nam, K.; Belcher, A.; Hammond, P., ACS Nano, 2008; 
Vol. 2, pp 566-571. 
Douglas, T.; Young, M.; Belcher, A.; Solis, D.; Willits, D.; Klem , M., Adv. Func. Mats. 
2005, 15, 1489-1494. 
Nam, K.; Kim, D.; Yoo, P.; Chiang, C.; Meethong, N.; Hammond, P.; Chiang, Y.; 
Belcher, A., Science 2006, 312 (5775), 885-888. 
Mulvaney, P., Langmuir 1996, 12, 788-800. 
63 
Eaton, B. E.; Feldheim, D. L., ACS Nano 2007, 1. 
Peelle, B. R.; Krauland, E. M.; Wittrup, K. D.; Becher, A. M., Langmuir 2005, 21. 
Slocik, J. M.; Wright, D. M., Biomacromolecules 2003, 4. 
Sewell, S. L.; Wright, D. W., Chem. Mater. 2006, 18, 3108-3113. 
Huang, Y.; Chiang, C. Y.; Lee, S. K.; Gao, Y.; Hu, E. L.; De Yoreo, J.; Belcher, A. M., 
Nano Lett. 2005, 5. 
Sethi, M. J., G.; Knecht, M. R., Langmuir. 2009, 25. 
Petty, J. T.; Zheng, J.; Hud, N. V.; Dickson, R. M., J. Am. Chem. Soc. 2004, 126 (16), 
5207-5212. 
Ritchie, C. M.; Johnsen, K. R.; Kiser, J. R.; Antoku, Y.; Dickson, R. M.; Petty, J. T., J. 
Phys. Chem. C. 2007, 111. 
Ma, N.; Sargent, E. H.; Kelley, S. O., Journal of Materials Chemistry 2008, 18, 954-64. 
Dooley, C.; Rouge, J.; Ma, N.; Invernale, M.; Kelley, S., J. Mater. Chem. 2007, 17 (17), 
1687. 
Park, J.; Privman, P.; Matijevik, E., J. Phys. Chem. B. 2001, 105, 11630-11635. 
Amemiya, Y.; Arakaki, A.; Staniland, S. S.; Tanaka, T., Biomaterials 2007, 28. 
Kisailus, D.; Choi, J. H.; Weaver, J. C.; Yang, W. J.; Morse, D. E., Adv. Mater. 2005, 17. 
Richards, C. I.; Choi, S.; Hsiang, J.; Antoku, Y.; Voshc, T.; Bongiorno, A.; Tzeng, Y.; 
Dickson, R. M., J. Am. Chem. Soc. 2008, 130, 5038-5039. 
Taton, T. A.; Mucic, R. C.; Mirkin, C. A.; Letsinger, R. L., J. Am. Chem. Soc. 2000, 122. 
Nam, K.; Kim, D.; Yoo, P.; Chiang, C.; Meethong, N.; Hammond, P.; Chiang, Y.; 
Belcher, A., Science 2006, 312 (5775), 885-888. 
Zheng, J. Z., C.; Dickson, R.M. , Highly Fluorescent, Water-Soluble, Size-Tunable Gold 
Quantum Dots. Phys. Rev. Lett. 2004, 93 (7). 
Shimizu, K.; Cha, J.; Stucky, G. D.; Morse, D. E., Proc. Natl. Acad. Sci. U.S.A. 1998, 95, 
6234-6238. 
Roth, K. M.; Zhou, Y.; Yang, W. J.; Morse, D. E., J. Am. Chem. Soc. 2005, 127, 325-
330. 
Gugliotti, L. A. F., D.L.; Eaton, B.E., J. Am. Chem. Soc. 2005, 127, 17814-17818. 
Dolska, M. In Vitro Selection of RNA Sequences that Mediate the Formation of Iron 
Oxide Nanoparticles. North Carolina State University Raleigh, 2007. 
64 
Eaton, B. E., Curr. Opin. Chem. Biol. 1997, 1. 
Eaton, B. E. P., W. A., Annu. Rev. Biochem. 1995, 64. 
Mcintyre, N. S.; Zetaruk, D. G., Anal. Chem. 1977, 49. 
Schwertmann, U., J. Colloid Interface Sci. 1999, 209, 215. 
Jansen, E.; Kyek, A.; Schafer, W.; Schwertmann, Appl. Phys. A: Mater. Sci. Process. 
2002, 74, S1004-S1006. 
Majzlan, J.; Navrotsky, A.; Schwertmann, U., Geochim. Cosmochim. Acta 2004, 68. 
Scheinost, A.; Schwertmann, U., Soil Sci. Soc. Am. J. 1999, 63, 1463. 
Schwertmann, U.; Carlson, L., Clay Miner. 2005, 40. 
Schwertmann, U.; Stanjek, H.; Beecher, H. H., Clay Miner. 2004, 39. 
Taylor, R. M.; Schwertmann, U., Clay Miner. 1974, 10. 
Taylor, R. M.; Schwertmann, U., Clay Miner. 1974, 10, 10. 
Flynn, C. M., Chem. Rev. 1984, 84. 
Jambor, J. L.; Dutrizac, J. E., Chem. Rev. 1998, 98. 
Jolivet, J. P.; Tronc, E.; Chaneac, C., C. R. Chim. 2002, 5. 
Jolivet, J. P.; Chaneac, C.; Tronc, E., Chem. Commun. 2004. 
Carter, C. J.; Dolska, M.; Owczarek, A.; Ackerson, C. J.; Eaton, B. E.; Feldheim, D.   L., 
J. Mats. Chem. 2009, 19 (44), 8320-8326. 
Gugliotti, L. A.; Feldheim, D. L.; Eaton, B. E., Science 2004, 304 (5672), 850-852. 
Gugliotti, L. A.; Feldheim, D. L.; Eaton, B. E., 2005, 127 (50), 17814-17818. 
Liu, D. G.; Gugliotti, L. A.; Wu, T.; Dolska, M.; Tkachenko, A. G.; Shipton, M. K.; Eaton, 
B. E.; Feldheim, D. L., 2006, 22 (13), 5862-5866. 
Nam, K. T.; Kim, D. W.; Yoo, P. J.; Chiang, C. Y.; Meethong, N.; Hammond, P. T.; 
Chiang, Y. M.; Belcher, A. M.,  Science 2006, 312 (5775), 885-888. 
Dooley, C. J.; Rouge, J.; Ma, N.; Invernale, M.; Kelley, S. O.,  Journal of Materials 
Chemistry 2007, 17 (17), 1687-1691. 
Petty, J. T.; Zheng, J.; Hud, N. V.; Dickson, R. M., Journal of the American Chemical 
Society 2004, 126 (16), 5207-5212. 
Dickerson, M. B.; Naik, R. R.; Stone, M. O.; Cai, Y.; Sandhage, K. H.,  Chemical 
Communications 2004,  (15), 1776-1777. 
65 
Slocik, J. M.; Naik, R. R.; Stone, M. O.; Wright, D. W.,  Journal of Materials Chemistry 
2005, 15 (7), 749-753. 
Nygaard, S.; Wendelbo, R.; Brown, S.,  2002, 14 (24), 1853-1856. 
Naik, R. R.; Stringer, S. J.; Agarwal, G.; Jones, S. E.; Stone, M. O.,  Nature Materials 
2002, 1 (3), 169-172. 
Nam, K. T.; Wartena, R.; Yoo, P. J.; Liau, F. W.; Lee, Y. J.; Chiang, Y. M.; Hammond, 
P. T.; Belcher, A. M.,  Proceedings of the National Academy of Sciences of the 
United States of America 2008, 105 (45), 17227-17231. 
Habib, A.; Tabata, M.; Wu, Y. G.,  Bulletin of the Chemical Society of Japan 2005, 78 
(2), 262-269. 
Nam, K. T.; Lee, Y. J.; Krauland, E. M.; Kottmann, S. T.; Belcher, A. M., Acs Nano 
2008, 2 (7), 1480-1486. 
Eaton, B. E.; Feldheim, D. L., ACS Nano 2007, 1 (3), 154-159. 
Masson, J. F.; Gauda, E.; Mizaikoff, B.; Kranz, C., Analytical and Bioanalytical 
Chemistry 2008, 390 (8), 2067-2071. 
Chen, H. J.; Kern, E.; Ziegler, C.; Eychmuller, A.,Journal of Physical Chemistry C 2009, 
113 (44), 19258-19262. 
Cha, J. N.; Shimizu, K.; Zhou, Y.; Christiansen, S. C.; Chmelka, B. F.; Stucky, G. D.; 
Morse, D. E., Proceedings of the National Academy of Sciences of the United 
States of America 1999, 96 (2), 361-365. 
Curnow, P.; Bessette, P. H.; Kisailus, D.; Murr, M. M.; Daugherty, P. S.; Morse, D. E.,  
Journal of the American Chemical Society 2005, 127 (45), 15749-15755. 
Kisailus, D.; Choi, J. H.; Weaver, J. C.; Yang, W. J.; Morse, D. E.,Advanced Materials 
2005, 17 (3), 314. 
Ball, P., Nature 2003, 421, 422-422. 
Jensen, G. J.; Briegel, A., Current Opinion in Structural Biology 2007, 17, 260-267. 
Carter, C.; Dolska, M.; Owczarek, A.; Ackerson, C.; Eaton, B.; Feldheim, D., J Mater 
Chem 2009, 19 (44), 8320. 
Carter, C. J.; Ackerson, C. J.; Feldheim, D. L., ACS Nano 2010, 4, 3883-3888. 
Butts, C. A.; Swift, J.; Kang, S.; Constanzo, L.; Christianson, D. W.; Saven, J. G.; 
Dmochowski, I., Biochemistry 2008, 47, 12729-12739. 
66 
Uchida, M.; Klem, M.; Allen, M.; Suci, P.; Flenniken, M.; Gillitzer, E.; Varpness, Z.; 
Liepold, L.; Young, M.; Douglas, T., Adv. Mater. 2007, 19, 1025-1042. 
Andrews, S. C.; Arosio, P.; Bottke, W.; Briat, J.; von Darl, M.; Harrison, P. M.; Laulhere, 
J.; Levi, S.; Lobreaux, S.; Yewdall, S., J. Inorg. Biochem. 1992, 47, 161-174. 
Arakaki, A.; Webb, J.; Matsunaga, T., Journal of Biological Chemistry 2003, 278 (10), 
8745-8750. 
Malone, S.; Lewin, A.; Kiic, M.; Svistunenko, D.; Cooper, S.; Wilson, M.; Le Brun, N.; 
Spiro, S.; Moore, G., JACS 2003, 126 (2), 496-504. 
Wong, S.; Tom-Yew, S.; Lewin, A.; Le Brun, N.; Moore, G.; Murphy, M.; Mauk, A., 
Journal of Biological Chemistry 2009, 284 (28), 18873-18881. 
Amemiya, Y.; Arakaki, A.; Staniland, S. S.; Tanaka, T., Biomaterials 2007, 28. 
Harrison, P. M.; Arosio, P., Biochim. Biophys. Acta 1996,  (275), 161-203. 
Gifford, J., 2010. 
Briegel, A., 2010. 
Asharani, P.; Low Kah Mun, G.; Hande, M.; Valiyaveettil, S., ACS Nano 2008, 3 (2), 
279-290. 
Schmidt, T.; Skerra, A., Nature 2007, 6 (2), 1528-1535. 
 
 
 
 
 
 
